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ABSTRACT 
Roles of Igh Intronic Enhancer E  in Clonal Selection at the Pre-B to Immature B Cell 
Transition and in the Elimination of Autoreactive B Cells 
By  
Cheng Peng 
Adviser: Professor Laurel A. Eckhardt 
The immunoglobulin heavy chain locus (Igh) intronic enhancer, E , enhances transcription of 
recombined Igh genes. We have previously shown that in mice with an E -deficient Igh allele 
(VH
a
), Ig  is expressed at half of the wild-type levels in pre-B cells. We also described an E -
dependent “check-point”, operating at the pre-B to immature B cell transition, for heavy chain 
allelic exclusion. We now show that deletion of E  results in a smaller immature B cell 
compartment, and the pre-BCR/BCR signaling is diminished in pre-B cells as a result of the 
reduced Ig  levels, making it difficult for emerging BCRs to reach the signaling threshold 
required for positive selection of pre-B cells to the immature B cell stage.  
Our hypothesis is that, to circumvent the problem of inadequate signaling, E -deficient B cells 
either 1) expand the rare precursor B cells seemingly breaking the rules of allelic exclusion to 
express a second IgH allele as “double-producers”, to achieve higher levels of Ig -chain and 
hence higher pre-BCR and BCR levels, or 2) undergo heightened light-chain editing to create an 
IgH/IgL combination with superior signaling properties to make up for the lower Ig -chain 
(lower BCR) levels and signaling. To test these hypotheses and to determine whether escape 
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from the developmental defects in E -deficient B cells is dependent upon light chain, we 
provided the E -deficient mice with a pre-assembled VL gene (3-83V ). This led to not only a 
larger immature B cell compartment, but also a decrease in “double-producers”. We suggest that 
an IgH/IgL combination with superior signaling properties may compensate for the reduced BCR 
levels and eliminate the selective advantage of “double-producers”. 
We also find that “double-producers” in E -deficient heterozygous mice (VH
a
/WT
b
), include a 
subpopulation with autoreactive BCRs. We infer that the BCRs with IgH from the VH
a
 allele 
are ignored during negative selection at the pre-B to immature B cell transition, due to their low 
density. Instead, the double-producers are both positively and negatively selected on the basis of 
BCRs with IgH from the alternate allele (with E  intact). Taken together, these results suggest 
that E  functions to ensure sufficient Ig (IgH) levels at the pre-B to immature B transition, 
which has an important impact on the maintenance of heavy chain allelic exclusion, the breadth 
of the BCR repertoire, and the elimination of autoreactive B cells. 
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Chapter 1 Introduction 
1.1. Basics of the immune system 
Living in a microbial and complex environment, we have a highly evolved immune system 
which is able to distinguish between foreign and self molecules and protect us from diseases. Our 
immune system effectively and efficiently detects and fights against a wide variety of pathogens, 
including viruses, bacteria, fungi, or parasitic worms. In some cases, the immune system also 
functions to destroy abnormal (like cancerous cells) or dying body cells. Due to the enormous 
number of invasive agents and various ways of infection, multiple defense mechanisms have 
been adopted and numerous cells and molecules participate in the host’s immune response (1, 2).  
Physical barriers are the first line of defense when the body is invaded. These include 1) 
mechanical barrier which expels or traps microbes, like the skin, or mucous membrane; 2) 
chemical barrier consists of substances that lyse or break down infectious cells, such as lysozyme, 
gastric acid, proteases, or collectins; and 3) biological barrier competitively limits the food or 
space supply for the pathogenic bacteria, for example the commensal flora in the gastrointestinal 
tract. 
Once the host’s physical barriers are passed, the innate immune system immediately starts to 
defend non-specifically against the invaders (3). With invariant receptors, the innate immune 
system recognizes the common features of pathogenic components. Microbes or other foreign 
molecules can be engulfed and destroyed by phagocytes (including macrophages, granulocytes, 
dendritic cells, etc). Natural killer cells (NK cells) are a type of cytotoxic lymphocyte critical to 
the innate immune system. NK cells do not directly attack invading microbes. Instead, they 
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destroy infected cells or tumor cells (4, 5). Inflammation recruits immune cells (mainly 
leukocytes) to the site of infection by cytokine signals to fight against the invasions (6-8). 
Complement system, as the humoral component of innate immune system, “complements” the 
abilities of antibodies and phagocytic cells to clear pathogens (9, 10). The complement system 
consists of a series of small proteins, which function to 1) enhance phagocytosis of antigens 
(opsonization) by marking the antigens, 2) attract inflammatory cells (chemotaxis), such as 
macrophages and neutrophils, to the site of infection, and 3) form membrane-attack complex 
(MAC) to rupture the cell membranes and lyse the cells (11). The innate immune system does 
not confer long-lasting protection to the host. Rather, it provides immediate defense against 
infections. 
If the innate immunity is also evaded, the adaptive immune system then takes place in an antigen 
specific manner (12, 13). The adaptive immune system works together with the innate immune 
system, but is highly specific to the particular pathogen which induced it and may provide long-
lasting protection for the host due to the immunological memory (14) (discussed in section 1.2). 
These three layers of defense with increasing specificity allow us to survive in the potentially 
pathogenic world. 
1.2. The adaptive immune system 
The adaptive immune response is carried out by a subset of leukocytes: the lymphocytes (15). T 
and B lymphocytes are the two major cellular members of the adaptive immune system, and they 
are involved in the cell-mediated and humoral immune responses, respectively. Both T and B 
lymphocytes have diverse specific receptors on their surfaces so that they can recognize and 
target the pathogens (16). According to the clonal selection theory, each lymphocyte has a single 
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type of receptor on its surface with single antigen specificity (17, 18). Cells with specificity to 
self-molecules are removed from the repertoire during early stages of their development, while 
those that recognize only foreign molecules survive and are activated once they encounter their 
matching antigens (19). When activated by the cognate antigens, T and B lymphocytes develop 
into memory cells and are able to mount a faster and stronger reaction once re-infected by the 
same pathogen. Activated T cells react against antigens that are presented by the host cells, 
whereas activated B cells secrete antibodies which bind to antigens for destruction (16).  
1.3. Antibody expression 
Antibody, also known as immunoglobulin (Ig), is one of the crucial components of the adaptive 
immune system (20). Antibodies, produced by B lymphocytes, can bind and neutralize pathogens 
to block their access to the host cells. Antibodies may also coat pathogens for opsonization to 
facilitate phagocytosis. In addition, natural antibodies produced without previous infection, are 
able to trigger the classical complement pathway to destroy and eliminate the pathogens (21, 22).  
To fight against a large variety of antigens, antibody molecules are highly diversified, but 
sharing some common structural features (23). Antibody molecules are either secreted (except 
for IgD), or expressed on B cell surface (sIg) in a membrane-bound form. The sIg complex 
associates with the signal transduction molecules Ig  and Ig  to form B cell receptors (BCR), 
which actively control the selection processes during B cell development (24). Secreted Ig fight 
against antigens as monomers (like IgG and IgE) or multimers (like IgA and IgM). IgM 
molecules are usually secreted and synthesize pentamers, whereas IgA molecules form dimers. 
Each subunit in these multimers are linked by disulfide bonds and joined to a joining (J) chain 
peptide molecule (22). 
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1.3.1 Structure of immunoglobulin 
Each Ig molecule is a Y-shaped, symmetrical glycoprotein consisting of two identical heavy (H) 
chains and two identical light (L) chains, held together by inter-chain and intra-chain disulfide 
bonds (Figure 1.1). Each chain has a variable (V) and a constant (C) region. The V regions at the 
amino (N)-terminal are the antigen-binding domains that display variability and specificity. V 
regions differ in antibodies produced by different B cells, but are the same for all antibodies 
produced by a single B cell. The variable region of an Ig molecule contains 4 framework regions 
(FRs) and 3 complementarity determining regions (CDRs). The FRs are -pleated sheet 
structures which support in position the CDRs (the hypervariable region, in contact with antigens) 
(25). The V region of an IgH or IgL is composed of one immunoglobulin domain, and is ~110 
amino acids long. The C regions at the carboxy (C)-terminal of the heavy chain loci are the 
determinants of Ig isotypes or classes, and therefore determine the effector functions of the 
antibodies (26). The C regions are identical in all antibodies of the same isotype, but differ in 
antibodies of different isotypes. The C regions of IgH contain three or four immunogobulin 
domains depending on the class of the antibody, and C regions of IgL contain only one 
immunoglobulin domain. Each of the constant immunoglobulin domain is also ~110 amino acids 
long.  
There are five known types of Ig heavy chain in human and murine: Ig , Ig , Ig  (subdivided to 
Ig 1, Ig 2a, Ig 2b and Ig 3 in mice), Ig  and Ig . They define the classes (or isotypes) of 
immunoglobulins: IgM, IgD, IgG (subdivided to IgG1, IgG2a, IgG2b and IgG3 in mice), IgE and 
IgA, respectively. Antibodies of different classes possess their own structures and functional 
activities. For example, the C regions of Ig , Ig  and Ig , consisting of three tandem 
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immunoglobulin domains and one hinge region for flexibility, are ~330 amino acids long. The C 
regions of Ig  and Ig , both composed of four immunoglobulin domains, are ~440 amino acids 
long (27). IgG is the major class of antibody in circulation whose functions include but not 
limited to coating pathogen surface for the recognition by phagocytes, activating the classical 
complement pathway to eliminate pathogens, and immobilizing antigens by binding them 
together via agglutination. Whereas IgE plays an essential role in immunity to parasites, or to 
trigger mast cells or basophils to release histamine. IgA, found in mucous secretions, protects the 
hosts against microbes growing in body secretions. There are two types of Ig light chains in 
mammals, kappa ( ) and lambda ( ) light chains, in association with the Ig heavy chains (28). 
As discussed before, a light chain has two successive domains: one variable domain and one 
constant domain, ~220 amino acids long (Figure 1.1). The overall structures of Igh, Ig  and Ig  
loci are discussed below (section 1.3.2 and 1.3.3). 
The two arms of the Y-shaped antibody are also called the Fab (fragment, antigen binding) 
region. It is composed of the V region and one constant immunoglobulin domain at the N-
terminal from each heavy chain and each light chain (25). The base of the Y-shaped antibody is 
called the Fc (fragment, crystallizing) region. It consists of the remaining two or three of the 
constant immunoglobulin domains at the C-terminal from the two heavy chains (Figure 1.1). Fab 
and Fc regions can be cleaved by proteolytic enzyme papain or pepsin. Fab region, which 
contains the V region with varied antigen specificity, binds to antigens. Fc region interacts with 
Fc receptors or proteins of the complement system to mediate different physiological effects of 
antibodies, for appropriate immune responses to different antigens (27, 29). 
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Figure 1.1: The schematic structure of an IgG antibody molecule.  
An antibody (Ig) molecule consists of two identical heavy chains and two identical light chains. 
Each heavy chain and each light chain consists of an antigen-binding variable region (VH or VL, 
shown in dark angled boxes as indicated), and a constant region (CH or CL, shown in open angled 
and vertical boxes as indicated). The V region determines the specificity of an antibody, and the 
C region determines the effector function of an antibody. Function domains are shown, with 
interchain and intrachain disulfide bonds. Of an IgG antibody, each V region has one 
immunoglobulin domain, each CH region has three immunoglobulin domains (CH1, CH2, and 
CH3) and a hinge region, and each CL has one immunolobulin domain. Each immunoglobulin 
domain is depicted as a rectangle. Fab, Fc, and hinge regions are indicated. 
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1.3.2 The heavy chain locus 
The mouse heavy chain locus (Igh) spans around 3 megabases (Mb) on chromosome 12 (30, 31). 
The Igh comprises V-region in the 5’ part and C-region in the 3’ part. The V-region includes 
arrays of gene segments: the variable (VH), diversity (D) and joining (JH) gene segments. The C-
region includes a cluster of CH exons encoding different constant domains (Figure 1.2).  
Mouse Igh locus contains hundreds of VH gene segments (i.e. approximately 150 VH genes in 
C57BL/6J mice, spanning ~2.5 Mb) (32, 33), 9-12 DH gene segments according to mouse strains, 
and 4 functional JH gene segments (JH1-JH4) (32, 34, 35). There are different families of the VH, 
D and JH segments classified by sequence similarities (32, 34, 35). Among the 14 VH family gene 
clusters, at the 5’ most lies the VHJ558 family as distal VH genes. The most downstream VH gene 
family is VH7183, which are referred to as the proximal VH genes and are separated from the first 
D gene segment DFL16.1, by a 98 kilobase (kb) intergenic region (36). There are four D gene 
families. The most downstream D gene segment is DQ52, lying less than one kb upstream of the 
JH gene cluster. A leader (L) sequence exists 5’ of each VH gene segment, which encodes a 
leader peptide (i.e. a signal sequence) to signal the transportation of the newly synthesized IgH 
chain into the endoplasmic reticulum for surface expression or secretion. This leader peptide is 
excised in the final IgH chain (discussed in section 1.3.5).  
There is a cluster of Igh C-region (CH) gene segments (~200 kb), lying downstream of the JH 
genes. Different Ig classes (isotypes) and subclasses (allotypes) are encoded by the different CH 
exons, including C , C , C 3, C 1, C 2b, C 2a, C  and C  in murine (Figure 1.2).  
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Figure 1.2: The mouse heavy chain locus.  
Schematic view of murine Igh locus. There are four gene clusters on the Igh locus. All VH, D, JH 
and CH gene segments are in germline configurations but not shown to scale. Dark filled boxes = 
VH coding segments; hatched boxes = JH coding segments; open boxes = D or CH coding 
segments as indicated. Not all VH genes nor all D genes are shown. Slash marks indicate DNA 
regions not shown. A leader (L) sequence upstream of each VH gene segment is shown as a gray 
box. All CH genes are shown as indicated in Greek letters. Swith regions upstream from CH 
exons are shown as vertical gray ovals. Murine Igh locus consists of several cis-control elements: 
the intronic enhancer E  and the 3’ regulatory region (3’RR), represented by horizontal black 
ovals. E is composed of a core enhancer region (cE ) and two flanking matrix attachment 
regions (MARs). Seven DNase I hypersensitive enhancers have been identified within the 3’RR, 
designated hs3a, hs1,2, hs3b, hs4, hs5, hs6 and hs7.  
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1.3.3 The light chain locus 
The mouse kappa ( ) light chain locus is on chromosome 6, and the lambda ( ) light chain locus 
is on chromosome 16 (Figure 1.3). Ig  locus spans ~1.25 Mb, consisting of approximately 140 
V  genes at the 5’ of the locus, followed by 5 J  genes, and a single C  gene segment at the 
downstream of the locus. The germline  chain locus has three V  gene segments, four J  gene 
segments and four C gene segments. The J  and C segments are arranged in pairs (Figure 1.3). 
There are many more V  genes as compared to the only three V  genes. However, there is only 
one kappa light chain class due to the single C  coding sequence, and three lambda chain classes 
( 1- 3) encoded by three of the four C  coding sequence (C 4 is a pseudogene and incapable of 
coding proteins) (28, 37). Murine express kappa light chains in most of their immunoglobulins. 
Only ~5% of immunoglobulins in most normal inbred mice carry the lambda light chains, of 
which ~80% are 1 and the remaining ~20% are 2 and 3 (37, 38). 
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Figure 1.3: The mouse  and  light chain loci.  
Schematic view of murine Ig and Ig  loci. There are three gene clusters on each light chain 
locus. All V (V ), J (J ) and C (C ) gene segments are in germline configurations but not 
shown to scale. Dark filled boxes = V (V ) coding segments; hatched boxes = J (J ) coding 
segments; open boxes = C (C ) coding segments. A leader (L) sequence upstream of each 
V (V ) gene segment is shown as a gray box. Not all V  genes are shown. Slash marks indicate 
DNA segments not shown. Enhancer regions within the Ig and Ig  loci are indicated as black 
horizontal ovals, iE  and E , respectively. 
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1.3.4 Recombination of immunoglobulin genes 
There is only a limited number of V, (D), J and C coding genes on Ig loci in comparison to the 
numerous specificity of the antibody repertoire. The great diversity of antibody specificity is 
achieved through random rearrangement of the several arrays of Igh and Igl genes, a process 
termed V(D)J recombination which occurs exclusively in B lymphocytes. For example, the V 
region of IgH is assembled from VH, D, and JH gene segments by V(D)J recombination (39). 
These rearranging gene segments (VH, D, and JH) are flanked by recombination signal sequences 
(RSSs) for the recombination process. Each RSS consists of one highly conserved palindromic 
heptamer, and one moderately conserved A/T rich nonamer sequence, with a non-conserved 12 
or 23 base pairs (bp) DNA spacer between them (Figure 1.4) (40). According to the 12/23 rule of 
recombination, only a pair of different spacer RSSs are able to recombine, so that the 12 bp RSS 
recombines only with the 23 bp RSS (40). The VH and JH gene segments are flanked by 23 bp 
RSS 3’ and 5’, respectively, whereas D segments are flanked by 12 bp RSS on both sides. 
Therefore, there is no direct VH to JH gene recombination since both of them are flanked by 12 
bp RSSs, resulting in an ordered VH-D-JH assembly. Similarly, V  gene segments are flanked at 
the 3’ by 12 bp RSS, and J  gene segments are flanked by 23 bp RSS at the 5’ end. The V gene 
segments are flanked by 23 bp RSS and the J  by 12 bp RSS (Figure 1.4). These complementary 
RSS pairs (12/23), therefore, ensure recombination between V  and J , as well as V  and J
. 
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Figure 1.4: RSS of mouse heavy and light chain loci.  
Schematic view of murine RSSs on the Igh, Ig and Ig  loci. Angled lines denote that not all 
DNA segments are shown, so the coding segments may be very far apart on the chromosome. 
Dark filled boxes = VH, V or V  coding segments; hatched boxes = JH, J or J  coding segments; 
open boxes = D, CH, C or C  coding segments as indicated. A leader (L) sequence upstream of 
each VH, V or V  gene segment is shown as a gray box.  
V, D and J gene segments are flanked by conserved heptamer and nonamer sequences with 
different spacers (drawn not to scale). Open and closed triangles denote Recombination Signal 
Sequences (RSSs) - their structures are indicated to the right (heptamer, spacer, nonamer). 
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The RSSs can be recognized by a common recombinase machinery including Rag1 and Rag2 
proteins (gene products of the recombination activating genes RAG1 and RAG2 on chromosome 
2 in murine). Rag1/2 proteins induce the DNA synapsis and double-strand DNA cleavage 
between the V, (D) and J coding gene segments and their flanking RSSs, forming hairpin loops 
at the coding ends (43, 44). These ends must be joined together to form contiguous coding DNA. 
Repair and joining of the DNA breaks require non-homologous end-joining (NHEJ) proteins: 
Ku70/80 proteins recruit the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) 
onto the coding end; DNA-PKcs activates artemis (a DNA endonuclease) to open the hairpins, 
which makes a random single cut (variable) near the tip of the hairpin, resulting in addition of a 
series of palindromic P-nucleotides at the coding end (45-47) (Figure 1.5). Addition of P-
nucleotides generates alternative amino acids at the coding joint, therefore creates the junctional 
diversity (or junctional flexibility). Subsequently, terminal deoxynucleotidyl transferase (TdT), 
adds further random N-nucleotides to the P-nucleotides of the V, D and J exons before the newly 
synthesized strands anneal to one another. This establishes additional diversity in the antibody 
repertoire. TdT is expressed at the pro-B cell stage during heavy chain gene assembly, but is 
turned down during light chain gene assembly (48, 49). Therefore, N-nucleotide additions to the 
light chain gene segments are not as common as to the heavy chain gene segments, resulting in 
less abundant junctional diversity on light chains. End joining is completed by DNA synthesis 
and repair machinery (X-ray repair cross-complementing protein 4 (XRCC4), DNA ligase IV, 
etc) (41, 48, 49), so that unpaired nucleotides are removed and gaps are filled (50) (Figure 1.5).  
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Figure 1.5: P- and N-nucleotides are included in the coding joints between gene segments 
during lymphocyte gene rearrangement.  
During joining of heavy chain V region coding sequences, P- and N-nucleotide additions occur 
after the RSS is cut and cleaved by RAG enzyme to form hairpin structures. The cleavage yields 
a single-stranded DNA end. During the subsequent repair, complementary nucleotides are added, 
forming P-nucleotides. In pro-B cells, N-nucleotides are added randomly by TdT before 
complementary pairing occurs, increasing the variability of the recombined gene segments. 
Nucleotide addition event is exemplified by a D to JH joining. Open boxes = D coding segments; 
gray filled boxes = JH coding segments. 
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The recombination at the Igh loci (in pro-B cells, see section 1.4) precedes the recombination at 
the Igl loci (in pre-B cells, also see section 1.4). D-to-JH gene recombination occurs on both the 
Igh loci, preceding VH-to-DJH recombination which occurs on only one of the two Igh alleles. 
Ig  loci recombination precedes Ig  recombination. Both Ig  alleles are rearranged but not 
functional in Ig -expressing B cells (51).   
1.3.5 Expression of immunoglobulin genes 
A human can produce more than 10
12
 different antibody molecules as a preimmune antibody 
repertoire. This enormous diversity of Ig specificities makes the antibody defense very 
formidable. The level of Ig proteins increases from precursor cells to the terminally differentiated 
(Ig-secreting) plasma cells. During the process of Ig gene expression, DNA rearrangement 
(through V(D)J recombination) is required, and only one of the two alleles is functionally 
expressed. After DNA rearrangement, the recombined gene becomes transcriptionally active 
because the promoter associated with the VH or VL gene segment is brought closer to the 
enhancer on Igh or Igl locus (E , iE , or E , Figure 1.2, 1.3). Transcription initiates from the 
promoter and produces a pre-mRNA which contains sequences of L, V(D)J and C exons as well 
as the introns between L and V(D)J and between V(D)J and C (also introns between subregions 
of the CH clusters in the case of Igh). This pre-mRNA is then spliced in the nucleus such that the 
remaining introns are removed, resulting in mRNA with contiguous L, V(D)J and C exons 
(Figure 1.6). The mRNA is translated in the cytoplasm into a nascent peptide, which is then 
transported into the lumen of the endoplasmic reticulum (ER). In the ER, the leader peptide is 
removed so that mature IgH (  or  protein) and IgL proteins assemble and the Ig molecule is 
inserted in the membrane (except for plasmacytes) or secreted via the route of secretory proteins.  
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Figure 1.6: Expression of immunoglobulin heavy chain protein. 
Schematic view of expression of murine Igh genes. There are four gene clusters on the Igh locus. 
All VH, D, JH and CH gene segments are in germline configurations but not shown to scale. Dark 
filled boxes = VH coding segments; hatched boxes = JH coding segments; open boxes = D or CH 
coding segments as indicated. A leader (L) sequence upstream of each VH gene segment is 
shown as a gray box. Switch regions upstream of CH exons are shown as vertical gray ovals. The 
intronic enhancer E  and the 3’ enhancer (3’RR) are represented by horizontal black ovals. Not 
all VH genes nor all D genes are shown. Slash marks indicate DNA segments not shown. All CH 
genes are shown as indicated in Greek letters. 
During the earlier stages of B cell development, the heavy chain variable region genes undergo 
VHDJH recombination. The recombined IgH gene is transcribed from the promoter (P) upstream 
of the recombined VHDJH gene, making a pre-mRNA with L, VHDJH, and CH exons as well as 
introns between them. This pre-mRNA is then processed (spliced) in the nucleus so that the 
introns are excised. The resulting mRNA with only L, VHDJH, and CH exons (with 5’ and 3’ 
untranslated regions) is translated in the cytoplasm. Although similar to transcription of light 
chain genes, transcription of heavy chain genes sometimes involves an alternative RNA splicing 
process, which generates different products (mRNAs for Ig  or Ig  heavy chains; Ig  not made 
in immature B cells). As the nascent polypeptide (protein) is transported into the lumen of the 
endoplasmic reticulum (ER), the leader peptide is removed, producing a mature  or  heavy 
chain (not shown). 
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A complete VHDJH recombination occurs on one of the two Igh loci. Transcription across the 
recombined IgH gene results in the formation of Ig  molecules. However, not all recombination 
leads to a functional Ig chain. In this case, the gene segments on the second allele recombine. 
After a functional heavy chain expression as an Ig  molecule, a V gene segment starts to 
rearrange with a J  gene segment. Once a productive V J  gene is expressed and able to pair 
with the Ig  heavy chain, a Y-shape mature Ig molecule is assembled. Only if recombination on 
both the  alleles fails, the  locus rearrangement takes place. 
As B cells mature, IgM
+
 B cells migrate to the secondary lymphoid organs (such as spleen and 
lymph nodes), where antibody class-switch recombination (CSR) occurs in response to antigen 
recognition and costimulatory signals. CSR is a deletional-recombination process that exchanges 
the CH (like C ) with one of a set of downstream CH genes (such as C 3, C 1, or C , etc). CSR 
requires the enzyme activation-induced cytidine deaminase (AID), to make DNA breaks at 
switch (S) regions, which precede the CH genes (52). dsDNA breaks are made within both the 
donor and acceptor S regions by a series of proteins, including AID, UNG, APE, etc, followed 
by the repair of DNA to make appropriate DNA ends for end joining. During the process of CSR, 
the intervening sequences between the two switch regions upstream of the two CH coding 
sequences involved are deleted as an episomal circle. CSR leads to a rearranged CH locus 
encoding a secondary isotype, retaining a functional antibody gene with the original specificity 
(the V region of IgH remains the same) but a distinct constant domain in their heavy chains. 
Cytokines stimulate transcription through the CH gene and determine the immunoglobulin 
isotype that the B cell will switch to. As a result, different daughter cells from the same activated 
B cells produce antibodies that retain the same specificity and affinity for the same antigen, but 
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in response to different cytokine signals, the antibodies produced are of different isotypes (e.g. 
IgM, IgG, IgE, etc.) and can interact with different effector molecules (53) (Figure 1.7).   
Besides CSR, somatic hypermutation (SHM) is another process that takes place within the 
germinal centers of secondary lymphoid organs. SHM is a largely random process which occurs 
in an individual B cell to adapt to antigens that confront it (54). SHM also involves the 
Activation-Induced Cytidine Deaminase (AID), causing high rate of point mutations (cytosine to 
uracil) in rearranged V region genes, following B cell exposure to antigens (Figure 1.7). Since 
uracil does not normally exist in DNA, to maintain the integrity of the genome, the uracil bases 
are removed by DNA glycosylase. Error-prone DNA polymerases then fill in the gaps which 
creates mutations at the mutated sites (55). SHM is generally considered as an affinity 
maturation process by which B cells produce antibodies with higher affinity for antigen.  
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Figure 1.7: The processes of heavy chain locus modification: VHDJH recombination, CSR 
and SHM. 
Schematic view of somatic modification events on murine Igh locus. There are four gene clusters 
on the Igh locus. All VH, D, JH and CH gene segments are in germline configurations but not to 
scale. Dark filled boxes = VH coding segments; hatched boxes = JH coding segments; open boxes 
= D or CH coding segments. A leader (L) sequence upstream of each VH gene segment is shown 
asa gray box. Swith regions upstream of CH exons are shown as vertical gray ovals. The intronic 
enhancer E  and the 3’ enhancer (3’RR) are represented by horizontal black ovals. Not all VH 
genes nor all D genes are shown. Slash marks indicate DNA segments not shown. All CH genes 
are shown as indicated in Greek letters. 
During the earlier stages of B cell development, the heavy chain variable region genes undergo 
VHDJH recombination and the recombined Igh locus expresses Ig  protein. During later stages of 
B cell development, the heavy chain locus undergoes class switch recombination (CSR) through 
the switch regions upstream of each CH gene segment, to produce antibodies of different classes 
but with the same antigen specificity. Individual B cells also undergo somatic hypermutation 
(SHM), during which process the Igh genes mutate to increase the affinity for an antigen. Both 
CSR and SHM involve the enzyme Activation-Induced Cytidine Deaminase (AID). 
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1.3.6 Control of V(D)J recombination 
The rearrangement of Igh and Igl loci is stringently regulated in a lineage, stage, and allele 
specific manner. This means that Ig molecules are expressed only in B lymphocytes, Igh gene 
expression precedes Igl gene expression, and only one of the Igh or Igl alleles is functionally 
expressed (35, 44, 56, 57). Regulation of V(D)J recombination in these contexts requires the 
collaboration of cis- and trans-acting factors, appropriate chromatin structure, as well as DNA 
breakage and repair mechamisms. Precise regulation of V(D)J recombination is crucial for Ig 
expression and ensures a competent adaptive immune system against invaders. Erroneous V(D)J 
recombination, in contrast, is a great threat to the integrity of the immune system. 
Essential to the process of V(D)J recombination, RAG1 and RAG2 genes are expressed only in 
developing lymphoid lineage cells, to control the cell-type and stage-dependent rearrangement of 
Ig and TCR genes in a specific order (58). Mice deficient of RAG1 or RAG2 gene lack B and T 
lymphocytes because of their inability to rearrange their Ig and T cell receptor (TCR) genes (59, 
60). Ig variable region gene recombination, by intrachromosomal deletion, is known to be an 
ordered process in which remodeling of Igh loci precedes Ig , and then Ig  loci. VH and JH 
segments are both flanked with 23 bp RSSs, preventing them from direct recombination. It has 
been noted that D-to-JH rearrangements generally occur as the first step of Ig recombination on 
both chromosomes, followed by VH-to-DJH rearrangements on one of the two alleles (39, 41, 61). 
Although VH to D rearrangement in the absence of D to JH joining is possible according to the 
12/23 rule, this is not observed in developing B cells (62). In addition, D-to-JH joints were 
observed in developing T lymphocytes, whereas VH-to-DJH joints were not found in T 
lymphocytes (63). Taken together, it has been suggested that the VH to DJH recombination is a 
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step that is regulated in the context of lineage specificity and allelic exclusion (also see section 
1.5) (44, 62). 
Although the mechanisms of ordered, allelic excluded Ig gene rearrangement are not fully 
understood, an accessibility model has been proposed to explain the lineage and stage specific 
recombination of Ig and TCR genes, with controlled/restricted accessibility of Rag proteins to 
RSSs of the V, (D), and J gene segments (39, 42, 51, 64, 65). The hypothesis of accessibility 
model was based on the observation that germline transcription of unrearranged Ig gene 
segments occurred prior to V(D)J recombination, making the genes “open” and accessible to the 
recombination machinery (35, 39, 51, 66). It is well known that Igh genes are rearranged in pro-
B cells but not in pre-B cells when Igl variable region genes are assembled. Correspondingly, the 
murine germline VH gene segments are found to be transcribed and produce germline transcripts 
(noncoding and unrearranged) only in pro-B cells that are actively undergoing VH to DJH joining, 
but not in B cells at other stages where there is no VH to DJH recombination occurring (51, 64). 
This concomitant of Igh gene recombination and germline transcription was also described 
during Igl gene recombination (67), suggesting an open chromatin structure required and 
provided for efficient Rag binding to RSSs (66). It has been proposed that the germline 
transcription at Ig loci leads to supercoiling which is necessary for RSS recognition by Rag1/2 
proteins (66).   
A lot of studies have been done to uncover the roles of germline transcript in the class switch 
recombination. It has been shown that germline transcripts upstream of CH genes aid to recruit 
the activation-induced cytidine deaminase (AID) to the DNA strand (68, 69). Accordingly, a 
similar mechanism might be applied for Ig gene rearrangements, to make the RSSs more 
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accessible for Rag proteins. An indirect evidence for the importance of germline transcripts in 
DNA recombination is that upon deletion of the promoter to prevent the germline transcription 
from the 5’ of D 1 on the  locus of TCR (comparable to the 0 transcript of the Igh locus, also 
see section 1.3.7), the rearrangement of the D 1 segment is destroyed, due to the diminished 
cleavage of RSS by Rag proteins (70). In general, these studies support a model that germline 
transcription of the Ig loci, as the initiation of V(D)J recombination, plays a role in regulating the 
accessibility of Rag to the recombining DNA sequences. In addition to the study of germline 
transcription according to the accessibility model, a number of chromatin modifications first 
identified as features of an “open” chromatin structure, correlate with V(D)J recombination 
accessibility at the corresponding locus. For example, over the past decades, it has been 
demonstrated that Ig genes accessible for recombination display chromatin modifications 
(histone acetylation or DNA demethylation) that are characteristics for active genes, during the 
early stages of B cell development (71-76) (also discussed in section 1.3.6). Further work needs 
to be done to elucidate whether germline transcription and its associated chromatin modifications 
are a cause or effect of DNA rearrangement of Ig loci. 
Enhancers and promoters throughout the Ig loci play a critical role in controlling the accessibility 
of the gene segments on the Ig loci. They have been implicated in making the neighboring 
chromatin in a Rag-accessible configuration (77). The Igh intronic enhancer E  is known to be 
critical for VHDJH recombination. Deletion of E  substantially impairs D-to-JH and VH-to-DJH 
rearrangements (78, 79). The MARs that flank the core region of E  are dispensiable for VHDJH 
recombination (80), and deletion of the hs3a, hs1,2 or hs3/hs4 regions of the 3’RR on Igh seems 
not to affect VHDJH recombination (81, 82) (also see section 1.9). Rearrangement at the Ig  locus 
was impaired but not abolished by the deletion of iE  or the 3’ E  alone (83, 84). But deletion of 
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both abrogated Ig  rearrangement (85). The controlled accessibility of Ig gene segments to Rag 
protein mediates DNA cleavage and recombination at only the appropriate time and place. Roles 
and mechanisms of these regulatory elements (enhancers, promoters, etc) in V(D)J 
recombination are still under active investigation. 
1.3.7 Germline transcripts 
Before D-to-JH gene recombination on the Igh locus, germline transcription initiates from the 
promoter of the 3’ most D gene segment (DQ52) and gets spliced to the C  region to generate the 
germline transcript 0 (39, 86), and the germline transcript I  initiating at E  also gets spliced to 
the C  region (87). Similar to 0 and I , germline VH gene segments are transcribed in the sense 
direction from the VH promoters before the onset of VH to DJH gene recombination. It should be 
noted that these VH promoters also initiate the transcription of the recombined VHDJH exon (88, 
89). The germline VH transcription is silenced once a productive VHDJH rearrangement is 
produced (51, 90). Introduction of a pre-rearranged  transgene resulted in a decrease in the 
endogenous VH germline transcript and a decrease in VHDJH recombination on the endogenouse 
Igh locus (91). An ~ 120 kb domain which includes the D gene segments and extends to the C  
exons was found to be hyperacetylated prior to the initiation of D-to-JH recombination, indicating 
an active form of Igh genes for transcription (where 0 and I  transcription occurs). However, 
germline VH genes were not hyperacetylated at this stage but were transcriptionally active at the 
subsequent stage when VH-to-DJH recombination occurs. This is consistent with the mechanism 
for the sequential recombination of D-to-JH gene segments, followed by VH-to-DJH 
recombination (92). It remains to be investigated whether accessibility depends on germline 
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transcripts, the process of germline transcription, or chromatin modification that accompany the 
transcription process (93). 
There are also two germline transcripts described for murine C  on the  light chain locus (94, 
95). One of the gemline transcripts initiates 3.5 kb upstream of the 1
st
 J  gene segment (J 1), 
which leads to a 8.4 kb primary transcript but produces a processed germline transcript of 1.1 kb 
(94, 96, 97). The other transcript initiates 50-100 bp upstream of the J  gene cluster, producing a 
4.7 kb transcript which is also processed, resulting in a 0.8 kb processed product (98). Disruption 
of these transcripts by deleting the promoters led to dramatic reduction in the frequency of DNA 
rearrangement at the targeted  locus (99, 100). To date, less about  locus germline transcripts 
has been identified. Known are germline transcripts initiating from the 5’ of the corresponding 
J  gene segments on each of the three functional J C  clusters and these transcripts are spliced 
to the C  segment (101, 102). Germline transcripts of the J C clusters were detectable two days 
later than the J C  transcripts in vitro, and this difference was also observed in vivo: germline 
transcripts of  loci were found in large pre-B cells whereas germline transcripts of  loci were 
first seen at the later developmental stage of small pre-B cells. This differential activation of  
and  loci is suggested to be one of the decisive factors for the sequential recombination of  and 
 light chain genes:  first and then , and for the 10:1 ratio of : present in murine.  
These murine germline transcripts are found at low abundance and there are either no or multiple 
start/stop sites in all three reading frames of these transcripts, suggesting that they do not encode 
proteins, such that they are also called “sterile” transcripts (94, 102). Despite the positive 
correlation between levels of germline transcripts and the efficiency of V(D)J recombination 
(103, 104), the definitive role of germline transcript/transcription in V(D)J recombination is still 
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under investigation and remains debated (105). For example, evidence for the correlation 
between Igh germline transcript and VHDJH recombination includes the finding that promoter of 
DQ52 turns to be active to generate the 0 transcript before the D-to-JH recombination (86, 106, 
107), and absence of 0 results in complete loss of D-to-JH gene rearrangement (79). However, 
impairment of I  germline transcription has no clear effect on VHDJH recombination (108).  
1.4. B cell development stages 
Murine B lymphocytes develop from progenitor cells in the fetal liver and in the bone marrow 
(BM) after birth, through sequential rearrangements of Igh and lgl chain genes (109, 110). 
Successful expression of the IgH and IgL chains on the cell surface is required for B cell 
development (109) (Figure 1.8). The progressive stages of B cell development are well defined 
on the basis of patterns of Igh and Igl gene rearrangements and expression, as well as the 
expression of various cell surface markers (110) (Table 1-1). 
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Figure 1.8: Flow chart of B cell development in mice. 
B cells develop from HSC to transitional B cells in the bone marrow, and then exit and enter the 
periphery, where they undergo further maturation to memory and Ig-secreting B cells upon 
activation. Stages of developing B cells are labeled under the cells with corresponding surface 
receptor (pre-BCR, BCR) expression. Naïve mature B cells in the germinal center may 
differentiate into plasma cells or memory B cells during the process of affinity maturation. Most 
of cells become plasmablasts, and eventually plasma cells producing Ig proteins. 
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Table 1-1: Cell surface markers expressed on B cells at different stages. 
The progressive stages of B cell development are well defined on the basis of expression of 
various cell surface molecules. 
Stage Location Cell surface markers 
Pro-B Bone marrow B220
+
CD43
+
IgM
-
 
Pre-B Bone marrow B220
+
CD43
-
IgM
-
 
Immature B Bone marrow B220
+
IgM
+
IgD
-
 
CD21
-
CD23
-
 
Newly formed transitional 1 (NF T1) Bone marrow B220
+
CD21
-
CD23
-
 
IgM
+
IgD
low
 
T2 Spleen B220
+
IgM
+
CD21
low
CD23
+
 
Mature B  
(FO) 
Spleen B220
+
IgM
+
IgD
+
 
(CD21
+
CD23
+
) 
Marginal zone B Spleen B220
+
IgM
+
CD21
+
CD23
low
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From HSC to lymphoid progenitor, then to B lineage cells 
Hematopoietic stem cells (HCS) are self-renewing and pluripotent. HSCs differentiate into IL-
7R
+
 common lymphoid progenitors (CLP) that give rise to B and T lymphocytes, as well as 
natural killer (NK) cells and dendritic cells (DC). B lineage cells are characterized by surface 
CD45R/B220 expression. The commitment to the B lineage from CLP is also marked by other 
processes, such as the expression of signaling molecules Ig  and Ig , surrogate light chain (SLC, 
including VpreB and 5 proteins), and germline transcripts of heavy chain locus, etc. This 
commitment is mediated by a series of transcription factors (111, 112). For example, PU.1 
protein is one of the well-known transcription factors, which controls IL-7R expression and thus 
controls the emergence of B lineage cells (113). The B-cell specific activator protein Pax5 not 
only activates B cell specific genes including CD19, BLNK, etc (114), but also represses 
alternative cell fates (115-118).  
Pro-B cell stage 
In the bone marrow, stromal cells secrete cytokines (such as IL-7) to induce TdT and RAG gene 
expression in lymphoid progenitor cells (CD34
+
). These cells undergo D-to-JH joining on the 
heavy chain loci (often on both alleles) and start expressing B220 (CD45
+
) and class II MHC 
molecules as early pro-B cells. Subsequently, VH segments recombine to the joined DJH on one 
of the two alleles, which completes the late pro-B cell stage.  
Because of the diverse coding ends generated during the recombination, the resulting 
transcription unit may not be in frame. If the recombined VHDJH sequence is non-productive, 
failing in synthesis of a heavy chain protein, VH-to-DJH assembly is attempted on the second Igh 
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allele. Failure in these two opportunities results in cell death. B cells eventually migrate from the 
outer part of the bone marrow to the core as the development goes on.  
Pre-B cell stage 
When the recombined VHDJH genes are expressed as membrane  chains and assemble with 
surrogate light chain proteins (SLC, include VpreB and 5 proteins) to form pre-B cell receptors 
(pre-BCR) on the cell surface, pro-B cells become pre-B cells (Figure 1.9). SLC resembles the 
real light chains but are invariant in all pre-B cells. The pre-BCR signals to shut down additional 
VHDJH rearrangement, so that only one functional heavy chain is expressed, a phenomenon 
known as allelic exclusion (39) (see section 1.5). TdT and RAG expression is down-regulated for 
this “feedback-inhibition” process. Now these large pre-B cells actively divide into a clone of B 
cells with identical  chains. After several rounds of proliferation, cells turn into the resting 
small pre-B cells and start VL-to-JL joining on the light chain loci by re-expressing the RAG1/2 
genes. Meanwhile, SLC levels decrease and IL-7R is no longer expressed. Light chains are also 
expressed in the allelic excluded manner, with  chain expression preceding  chain expression. 
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Figure 1.9: Expression of B cell receptors on developing B cells in the bone marrow. 
B cell receptor expression on surfaces of B cells at various differentiation stages, from pro-B cell 
stage through immature B cell stage in the bone marrow. Dashed lines = surrogate light chains; 
signaling subunit Ig as indicated. B cell receptors are tested at two checkpoints for cells 
progress to the next stage.    
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Immature B cell stage 
Once IgL chains are successfully expressed, they replace the SLC proteins and assemble with  
chains on the surface as IgM molecules, marking the immature B cell stage. Immature B cells are 
sensitive to antigen binding. If bound to self antigens in the bone marrow, the cells are negatively 
selected and undergo apoptosis, or can be rescued by receptor editing (see section 1.6). Further 
rearrangements at the light chain loci replace the auto-reactive specificity with a new functional, 
but non-self-reactive B cell receptor, allowing further maturation of these cells (119). Immature 
B cells that do not bind to self antigens pass the negative selection process. They develop into 
transitional B cells of type 1 (T1) as a precursor to transitional B cells of type 2 (T2, the cycling 
immigrants from the bone marrow to the spleen). 
Mature B cell stage 
Transitional B cells are the linker between BM immature B and the peripheral mature B cells. B 
cells mature in the spleen and co-express IgM and IgD (120). B cells are now mature naive 
resting cells, and can be activated in the periphery by foreign antigens and differentiate into Ig-
secreting plasma cells and memory B cells which respond more readily and quickly to the future 
exposure to the same antigens. B cells that fail to mature during development undergo apoptosis. 
IgM
+
IgD
+
 B cells in the bone marrow are re-circulating mature cells from the periphery (110). 
The Ig loci undergo further DNA modifications including CSR and SHM (Figure 1.7 and 
sections 1.3.5) (beyond the V(D)J recombination in pro- and pre-B cells), as the B cells mature. 
There are different types of mature B cells in mice. B-1 B cells develop from fetal precursors. 
They are self-renewing cells mainly in the peritoneal and pleural cavities. B-1 B cells secrete 
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“natural” antibodies against blood-borne antigens (121). Marginal zone (MZ) B cells in mice are 
noncirculating, self-repleshing mature B cells in the spleen. They share with B-1 B cells the 
feature of self-replenishment and capacity of quick response to antigens (122), and are capable of 
participating in early adaptive immune responses in a T cell independent manner, similar to B-1 
B cells (122). These cells localize at the border between the white and red pulp of the spleen. 
Follicular (FO) B cells and MZ B cells are both B-2 B cells, which develop from progenitor cells 
in the bone marrow, representing most of the mature recirculating B cells and reside in follicles 
of secondary lymphoid organs (123). 
FO B cells, comprising the majority of the recirculating B cells, respond to antigens in both T-
cell dependent and T-cell independent manners (123). Antigen recognition by FO B cells 
initiates T-cell dependent immune responses in the germinal centers of secondary lymphoid 
organs. B cells proliferate actively in the germinal centers with somatic hympermutation (SHM), 
resulting in modified antigen-specific B cells with higher affinities. Class switch recombination 
(CSR) is another process occurring after the activation of mature B cells via BCR, to generate 
antibodies of a secondary isotype, with a different effector function (see section 1.3.5, Figure 
1.7).  
In the current, we aim to further identify the control of B cell differentiation, especially at the 
pre-B to immature B cell transition. 
1.5. Allelic exclusion 
B cells expressing functional IgH and IgL chains are able to pair them and express an Ig 
molecule on the cell surface. Theoretically, there is potential for a B cell to express two distinct 
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functional VHDJH and four productive VLJL rearrangements (one on each chromosome of Ig  
and Ig  loci). Nevertheless, this is not what is observed in B lymphocytes. Each mature B cell 
contains only one productively rearranged VHDJH and one productively rearranged VLJL, and 
expresses only a single type of IgH/IgL combination. This unique feature of B lymphocytes (also 
applies to T lymphocytes) is reffered to as allelic exclusion (67, 124). According to the clonal 
selection theory, each B lymphocyte expresses a single-specificity antigen receptor on the cell 
surface so that the BCR repertoire is managed at the single cell level, allowing for an effective 
and efficient selection of the B cells with surface receptors (cells with protective receptors 
maintained, cells with autoreactive receptors eliminated) and a more rapid antibody response 
upon antigen recognition (17).  
As discussed before (section 1.3.4), rearrangement of Igh, Ig  and Ig  genes in developing B 
cells is a strictly ordered process. D and JH gene segments are recombined first in pro-B cells on 
both the Igh loci, followed by VH-to-DJH recombination on one of the two alleles. A complete 
VHDJH exon encodes the variable region of the IgH protein. Only if the rearrangement on the 
first allele is non-functional (out of frame or unable to pair with SLC as a pre-B cell receptor), 
cells proceed to recombine the second, alternative Igh allele, leading to allelically excluded 
expression of the heavy chain. Similarly, following IgH expression, only one allele of the light 
chain genes is productively rearranged and expressed to assemble with the IgH protein.  
A regulated model of allelic exclusion has been proposed (125), according to which, allelic 
exclusion is established because the initiation of V(D)J recombination of antigen receptor genes 
occurs on one allele at a time (67). Asynchronous allele opening for germline transcription and 
DNA/histone modification is thus suggested as the first step to regulate the mono-allelic 
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initiation of DNA recombination (124) (discussed in section 1.3.6, 1.3.7). The resultant 
functional receptors from the first allele inhibit V(D)J recombination on the second allele, a 
mechanism proposed to enforce allelic exclusion called feedback inhibition (discussed in the 
next paragraph). In these contexts, the regulated model for allelic exclusion includes two phases: 
initiation and maintainance. Mono-allelic initiation ensures allelic exclusion before the feedback 
signals (39). Because both Igh alleles are rearranged in the form of DJH in B lineage cells, VH to 
DJH recombination is the allelically excluded step in Igh locus recombination (39).    
Many studies have shown that once a functional V(D)J recombination has occurred on one allele, 
DNA recombination on the second allele is inhibitied, a process called “feedback inhibition” 
(Figure 1.10) (62, 125, 126). This “feedback” model is based on the premise that one allele 
recombines first and is tested for productivity and functionality (i.e. whether a recombined 
VHDJH can be translated to an Ig  protein, and whether this Ig  protein is able to pair with SLC), 
before the other allele is rearranged (125). According to the feedback inhibition model, 
functional Ig gene expression leads to assembly of pre-BCR or BCR to signal inhibition of 
additional Ig gene recombination through cessation of RAG gene expression or rendering Rag 
proteins inaccessible to the Ig loci, or silencing the germline gene segments (67, 124). In the case 
of the IgH chain, productively expressed IgH chain (Ig  protein) assembles with SLC and the 
signaling subunit Ig /  heterodimer, to “signal” suppression of allelic recombination (e.g. shut 
down expression of the RAG genes) (67, 127-129). But a growing number of evidences have 
suggested that, in fact, SLC is not required for this “feedback inhibition”. With deletion of the 
known SLC elements (VpreB, 5), allelic exclusion appears to be normal (130, 131). Rather, 
only productive membrane Ig  expression and Ig signaling molecules are crucial to the 
maintainance of intact IgH allelic exclusion (130-133).  
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Assuming that ~1/3 of V(D)J recombinations are productive (in-frame), this regulated model 
through feedback inhibition explains the 60/40 ratio (134): the observation that 60% of the 
peripheral mature B cells have successful VHDJH recombination on the first allele, and with DJH 
configuration on the second allele, whereas the other 40% cells have their Igh loci in the VHDJH 
(x)/VHDJH configuration (x= unproductive). The ratio of V J / 0 to V J  (x)/V J  cells is also 
around 60/40 in the periphery ( 0= germline transcript) (135), suggesting that the feedback 
inhibition model also applies to Ig light chain gene rearrangement.  
However, there is still possibility for the presence of more than one productively rearranged IgH 
or IgL loci in a single, mature B cell, which is called allelic inclusion. Allelic inclusion is more 
often seen in Ig light chains than Ig heavy chains (136-139). Several studies reported IgL (  or ) 
double-expressing B cells at low frequency in normal mice and human or at a higher frequency 
in transgenic mice (140-142). It should be noted that, even when a cell makes light chains from 
two different Igl alleles, the cell often expresses only one type of Ig receptor on the cell surface. 
This is because only one of the light chains successfully pairs with the available heavy chain. 
In summary, although actively studied during the past few years, mechanisms of allelic exclusion 
are still enigmatic. For example, the Ig locus transcriptional enhancers and promoters are known 
to be required for V(D)J recombination, however, how these cis-elements direct the DNA 
recombination process and their potential roles in allelic exclusion remain unclear (124). While 
we know that epigenetic marks at Ig loci (e.g. germline transcription, accessibility to Rags, active 
histone marks, etc) correlate with the strictly regulated monoallelic V(D)J recombination, the 
mechanisms of regulation at molecular levels are the next to be identified. It has been shown that 
all the Ig loci (Igh, Ig  and Ig ) replicate asynchronously, which is established randomly in early 
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embryogenesis and maintained as an epigenetic mark (67, 143). The early-replicating Ig  allele 
is the one that is epigenetically marked as the first allele for V  to J  recombination. However, 
both Igh loci are of the DJH configuration in pro-B cells, suggesting an active status for VH to 
DJH recombination at both loci. The definitive conclusions for the selection of one allele for 
monoallelic onset of VH to DJH recombination still require expremental proofs.  
Another question emerges after the finding of independence of IgH allelic exclusion on SLC. 
Although SLC is necessary for signaling cells to proliferate and differentate from pro-B to the 
pre-B cell stage, it is not required for signals that shut off further rearrangement on the second 
Igh allele. An unanswered question is what is the nature of this SLC-independent signal and how 
does it differ from that of the pre-BCR with SLC?  
As mentioned earlier, cells can carry two productively rearranged heavy or light chain loci 
(VHDJH/VHDJH or V J /V J or coexpress Ig  and Ig  chains). In some of these cells, one Ig 
allele encodes a  or  chain incapable of forming a surface expressed pre-BCR or BCR, such 
that allelic included Ig gene recombination display allelic exclusion at the level of surface 
receptor expression (132). However, in some cases, these allelic included Ig recombination 
results in peripheral B cells with two different IgH or IgL chains on the cell surface (more often 
seen in light chains) (137, 141, 142, 144, 145), suggesting that allelic exclusion prevalent in 
normal B cell development is not absolutely ensured nor 100% required for normal B cell 
development. Although such cells are rare, reasons for the escape from the stringent monoallelic 
initiation and feedback inhibition model for allelic exclusion need further studies. 
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Figure 1.10: Model for feedback inhibition of VH-to-DJH recombination. 
Igh locus rearrangement is ordered through the feedback regulation mechanism. Both Igh alleles 
are rearranged in pro-B cells in the form of DJH rearrangement, VH to DJH recombination is the 
step for feedback regulation. Pro-B cells that have made a productive VHDJH rearrangement on 
the first attempt do not initiate VH to DJH recombination on the second allele, with a freezed DJH 
on the second allele. This is achieved through the feedback signals from the functionally 
expressed Ig  molecules and Ig signaling subunits. This model predicts that if the cells make 
a nonfunctional VHDJH recombination on the first allele, they would rearrange VH to DJH on the 
second allele, leading to mature B cells carrying VHDJH rearrangements on both alleles (one 
productive and one nonproductive).  
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This current study attempts to address the mechanism for the maintainance of Ig heavy chain 
allelic exclusion at the pre-B to immature B cell transition, by heavy chain locus intronic 
enhancer E . A recent study on a mouse line that is heterozygous for a pre-assembled heavy 
chain variable region (VH) gene (B1-8VH) but lacked E  (VH
a
/WT
b
, Figure 1.11), showed a 
pronounced defect in allelic exclusion in both the immature and mature B cell pools (146). 
Approximately 20% splenic B cells in these heterozygous mice expressed Ig  from both VH
a
 
and WT
b
 Igh alleles as heavy chain “double-producers”. These IgH-“double-producers” were 
absent in the matched mouse line with the same B1-8VH knock-in gene but retained E  
(VHE
a
/WT
b
, Figure 1.11). This defect was not due to an inefficient feedback inhibition of Igh 
gene assembly in the VH
a
/WT
b
 pre-B cells. In fact, both the VH
a
 and VHE
a
 alleles strongly 
inhibited VH-to-DJH assembly on the WT
b
 allele. But neither allele operated this feedback 
inhibition completely (i.e. neither allele was successful in preventing VHDJH rearrangement on 
the second allele in every B lineage cell). Rather, there were rare but equal levels of precursor 
cells that circumvented this inhibition and expressed both the IgH alleles in the pre-B cell 
populations of both mouse strains. Nevertheless, these gave rise to IgH-double-producing 
immature B cells only in the VH
a
/WT
b
 mice but not in the VHEµ
a
/WT
b
 mice (146). Accordingly, 
we postulate that it takes some time for assembly of the pre-BCR subsequent to heavy chain 
variable region gene assembly. During this process of assembly, VH to DJH gene rearrangement 
takes place on the second allele in a subset of pre-B cells. Therefore, we proposed that there is a 
second “check-point” for heavy chain allelic exclusion operating after and distinct from the 
feedback inhibition, which occurs at the pre-B to immature B cell transition and is dependent 
upon the intronic enhancer E  (see section 1.9.1) (146).  
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Figure 1.11: Diagram of wild-type (WT
b
) and B1-8VH knock-in loci with and without Eμ 
(designated VHE
a
and VH
a
respectively).  
Exons are shown as boxes, enhancers are indicated as horizontal black ovals (E ; 3’ regulatory 
region = 3’RR), “switch” sequences (sites of class switch recombination) upstream of the 
constant region genes are indicated as vertical ovals, constant regions are labeled (e.g. , , etc.). 
B1-8VH is a pre-assembled VH gene that is inserted in place of the joining gene (JH) region. As 
indicated, the constant region genes in the knock-in loci are of the Ig
a
 allotype while they are of 
the Ig
b
 allotype in the WT locus. The WT
b
 allele in the heterozygotes is in the germline 
configuration, but if functionally rearranged, it would produce an Ig
b
 chain distinguishable 
from that produced by the knock-in loci (Ig
a
). 
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1.6. Positive and negative selection of B cells 
Developing B lymphocytes produce a highly diverse Ig/BCR repertoire essential for the defense 
against foreign pathogens. This diversity is achieved through random V(D)J gene recombination 
and IgH/IgL assembly. These processes simultaneously lead to the generation of B cells with 
null or self-reactive receptors that need to be removed from the repertoire by positive or negative 
selection, respectively. Positive selection is the process that has a minimum signaling 
requirement through the antigen receptors for the cell to survive and differentiate to the next 
stage (147). The BCR signals dictate the likelihood of nascent B cells to continuously 
differentiate and completely mature. B cells with adequate BCR signaling pass the positive 
selection process, so that a robust and protective mature B cell pool is established and maintained 
(147). 
During the process of maturation in the bone marrow and periphery, B cells are also tested for 
interaction with self-antigens, which is known as negative selection, to avoid production of B 
cells that may cause autoimmune diseases. B cells expressing receptors that bind to self antigens 
are negatively selected at the immature B cell stage. These selection processes also occur in the 
secondary lymphoid tissues to further insure a protective but non-autoreactive antibody 
repertoire. Currently well known negative selection mechanisms include clonal deletion, receptor 
editing, and anergy (148). Within the IgM
+
IgD
-
 immature B cell compartment, if the maturing B 
cells strongly interact with multivalent self antigens in the bone marrow, they undergo apoptosis 
and are clonally deleted. Those that recognize and bind to soluble self antigens are not killed, and 
instead, they move to the periphery and become anergic expressing low levels of IgM. Others 
that do not react to self antigens migrate to the periphery, expressing normal levels of IgM and 
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IgD, which are mature naïve B cells that might fight against their cognate antigens. Auto-reactive 
B cells may avoid apoptosis or anergy by modifying their receptor specificities, through 
secondary somatic Ig gene recombination to express new IgH and IgL combinations which 
replace the original specificity and become non-autoreactive. This is the mechanism called 
receptor editing, rescuing self-specific B cells to establish central tolerance (discussed in section 
1.8). 
1.7. B cell receptor signaling 
To achieve a diverse functionally competent, but non-autoimmune antibody repertoire, B cells 
undergo sequential gene expression and membrane assembly of receptors (pro-BCR, pre-BCR 
and BCR) to initiate the intracellular signaling pathways, which set thresholds for several 
selection checkpoints as B cells progress to the next stage. These signaling complexes all consist 
of an Ig heterodimer, carrying an immunoreceptor tyrosine-based activation motif (ITAM) in 
their intracellular domain. B cell antigen receptor mediated signaling is required throughout B 
cell development, peripheral maturation and repertoire selection (149).  
1.7.1 Pre-BCR signals 
The Ig signaling heterodimers associate with protein calnexin on the plasma membrane of 
pro-B cells. It has been proposed that this complex constitutes a pro-B-cell receptor that elicits 
intracellular differentiation signals for VHDJH gene assembly (150). Ig  is the product of the 
successfully recombined heavy chain gene (IgH). It assembles with the surrogate light chain 
(SLC) proteins ( 5 and VpreB), and then with the signaling subunit Ig Ig to form a pre-B cell 
antigen receptor complex (pre-BCR) on the pre-B cell membrane (151-153). The ability of Ig  
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chain to pair with the SLC is a quality control parameter to assess the  chain for successive B 
cell differentiation. This includes clonal expansion of Ig
+
 pre-B cells and allelic excluded 
expression of heavy chain loci. Monitored by the pre-BCR signaling, pre-B cells subsequently 
recombine their light chain genes and further differentiate to the immature B cell stage with 
surface IgM expression.  
Two checkpoints directed by pre-BCR have been defined during B cell development in the bone 
morrow. The 1
st
 one is for a functional heavy chain for B cells to progress to the pre-B cell stage, 
and the 2
nd
 one ensures a competent light chain for pre-B cells to differentiate into immature B 
cells (Figure 1.9) (154). Through activation and recruitment of a series of kinases, pre-BCRs 
(similar to BCR, discussed below) triggers a phosphorylation cascade to signal the 
developmental progression of pro- and pre-B cells, and hence the cells’ ability to progress to the 
immature B cell stage is tested at these two checkpoints.  
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1.7.2 BCR signals 
Rearranged immunoglobulin light chains (IgL) replace SLCs and form B cell receptors (BCRs), 
which define the immature B cell stage (149, 154, 155). To avoid autoimmunity, newly-
emerging B cells with self-reactive BCRs are subject to negative selection. Cross-linking the 
BCRs with self-antigen initiates cell signals that lead to cell death, anergy or light-chain “editing” 
which replaces the autoreactive BCR with an innocuous one (139, 156, 157) (discussed in 
section 1.6). On the other hand, tonic (or basal) signaling through the pre-BCR and BCR, 
independent of ligand-binding, is needed to select B cells with functional receptors (positive 
selection), promoting B cell maturation (158-160).  
Pre-BCR and BCR send out tonic signals in the form of tyrosine phosphorylation. Their 
signaling capacities are essential for the continuing B cell survival and maturation. Different 
status of protein tyrosine phosphorylation evokes differential cellular responses and determines 
the cell fates (149, 161) (Figure 1.12). 
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Figure 1.12: Pre-BCR mediated signaling model.  
The pre-BCR is composed of membrane Ig  molecules, SLC, and associated Ig heterodimers. 
Activation of pre-BCR induces coordinated activation of various signaling cascades. Central to 
this involves phosphorylation of ITAMs (immunoreceptor tyrosine-based activation motifs) in 
the cytoplasmic tails of Ig scaffold proteins, mediated by Src-family protein tyrosine kinases. 
Phosphorylated ITAMs recruit and activate Syk tyrosine kinase, which then activates multiple 
signaling pathways including: Erk pathway, PLC 2 pathway, etc. These pre-BCR-dependent 
pathways collectively regulate the transcriptional events to direct B cell fate decisions. 
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BCR signaling pathways start from receptors composed of both a signaling (Ig /Ig  heterodimer) 
and an antigen-binding (VH/VL of an Ig molecule) subunit. Antigen-mediated cross-linking of the 
antigen-binding moiety on Ig molecules is one way to initiate signal transduction into the 
cytoplasm of the cell, by way of the long cytoplasmic tails of the Ig /Ig  chains which associate 
with the Ig molecules. Pre-BCR signaling, however, does not always require exogenous ligands. 
Whether ligand-dependent or ligand-independent, activation of B cells through pre-BCR/BCR 
requires coordination of many different signal transduction pathways instead of any single 
transducer. One of the final outcomes of receptor signaling is stimulated or inhibited (or up- or 
down-regulated) transcription of the target genes, which, in turn, controls the intracellular events 
(such as DNA recombination) and the cellular activities (such as differentiation, proliferation). 
Defective signal transduction may have severe effects on the development of B cells and the 
immune system (149, 158-164). 
Ligand-independent activation of pre-BCR/BCR (i.e. tonic signaling) involves phosphorylation 
of tyrosine residues on ITAMs within the cytoplasmic domains of Ig cluster by Src-family 
protein tyrosine kinases (PTKs)(160) (Figure 1.12). These Src-family PTKs are associated with 
the receptors, including Lyn, Blk and Fyn in B cells. Phosphorylated ITAMs then provide 
docking sites for other PTKs to form a receptor signaling complex which triggers further 
downstream signaling events (165, 166). These include recruitment and activation of Syk, which 
is a vital PTK for B cell development (167). Activated Syk binding to the ITAM then activates a 
series of signaling proteins such as the adaptor protein BLNK (B-cell-linker protein), Btk 
(Bruton’s tyrosine kinase), etc (168). These initial signaling events provide a scaffold for the 
assembly of essential elements of the signaling complex. Syk phosphorylated BLNK is joined by 
Btk, and Btk activates phospholipase C 2 (PLC 2) to induce calcium flux and protein kinase C 
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(PKC) activation (169). It binds to Btk and PLC 2 to mediate the activation of PLC 2. BLNK is 
also necessary for activation of other signaling molecules such as Grb2, etc. Grb2 activates the 
extracellular signal-regulated kinase (ERK) pathway, which participates in the processes of cell 
expansion and differentiation (161, 170). BLNK is required for pre-BCR-mediated B cell 
development and BCR-mediated B cell activation (171-173). Src-family tyrosine kinases 
themselves activate nuclear factor- B (NF- B). Reciprocally, serine/threonine kinases 
negatively regulate ITAM activity by serine/threonine phosphorylation (149, 174). These 
tyrosine kinases may also be counterbalanced by protein tyrosine phosphatases (PTPs) (175). 
Therefore, the signaling quality and/or quantity through pre-BCR and BCR depends upon the 
balance between the activation of the signaling molecules through PTKs and the down-regulation 
through PTPs (176, 177).  
Alterations of BCR signaling components such as Syk or Btk, lead to abnormal B cell 
development. Reduced BCR expression results in diminished tonic BCR signaling, which 
significantly impairs immature B cell differentiation to mature B cells (178). Mutation studies of 
elements that participate in signal transduction from the BCR (Igα, CD45, and Btk), indicate that 
BCR signaling is indispensible for a diverse and protective B cell repertoire. These together 
suggest that pre-BCR and BCR signaling is qualitatively and quantitatively regulated in 
developing cells.  
1.8. Receptor editing 
Ig genes undergo V(D)J recombination to express a functional antigen receptor, and this is 
known as the primary somatic gene rearrangement. Receptor editing is the ongoing Ig gene 
rearrangement in cells that already have an antigen receptor, a process also known as secondary 
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rearrangement, which may occur on the same chromosome as the primary rearrangement or on 
the alternative one. Secondary rearrangement not only rescues cells expressing a nonproductive 
primary V(D)J gene, but also alters the autoreactive specificity of antigen receptors on self-
reactive B cells, rescuing them from apoptosis (19, 179-181). About 20-50% of peripheral naïve 
B cells have undergone receptor editing (182). Therefore, receptor editing acts as an important 
mechanism for self-tolerance. It also increases the chances for B cells to survive and therefore 
the efficiency of the production of a robust antibody repertoire. 
B cell receptor editing involves the same recombination machinery as the primary V(D)J 
rearrangement (e.g. Rag1 and Rag2 proteins). Receptor editing occurs mainly at the Ig light 
chain locus (also termed light chain editing), through V -J  or V -J  secondary rearrangements 
(179, 182-184). V  (V ) gene segments can rearrange to available J  (J ) gene segments by the 
12/23 rule. However, for the Igh locus, VH to DJH rearrangement deletes all the remaining D 
gene segments, which are required for VHDJH recombination on the Igh loci. Even though VH to 
VHDJH recombination occurs by a conserved heptamer sequence in some recombined VH gene 
segments (a process called VH replacement) (185, 186), the frequency of VH replacement is very 
much lower than light chain editing. For this reason, light chain editing is referred as a common 
process to modify BCR specificity. During the process of light chain editing, the rearranged 
V J  gene is replaced by a more upstream V  gene segment and a more downstream J  gene 
segment. Failing after multiple attempts on allele rearrangement, B cells start to express the  
allele (Figure 1.13). Autoimmune models have shown defective receptor editing, suggesting the 
importance of this process to prevent autoimmunity (187, 188). It has been noted that light chain 
editing may not delete the initial autoreactive IgL. Instead, light chain allelically- or isotypically-
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included B cells survive and mature, which may result in re-expression of the autoreactive 
specificity at the mature, Ig-secreting plasma B cell stage (179).  
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Figure 1.13: Model for light chain editing.  
Upper panel: Diagram for the process of light chain editing during the maturation of B cells. B 
cells can avoid apoptosis by modifying the light chain V  and J  genes so as to express a 
different specificity. If a cell fails to express a functional but non-autoreactive Ig , it starts to 
express the lambda light chain. 95% of normal peripheral B cells express the kappa light chain.   
Lower panel: Secondary kappa light chain recombination. During the process of light chain 
editing, the rearranged V J  gene is replaced by a more upstream V  gene segment and a more 
downstream J  gene segment. All V, J and C gene segments are in germline configurations but 
not shown to scale. Dark filled boxes = V coding segments; hatched boxes = J  coding segments; 
open boxes = C coding segment. A leader (L) sequence upstream of each V gene segment is 
shown as a gray box. Not all V  genes are shown. Slash marks indicate DNA segments not 
shown. 
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1.9. Regulators of Igh gene expression 
Several cis-regulatory elements are identified throughout the Igh and Igl loci (Figure 1.2, 1.3).  
On the Igh locus, enhancers are located between the JH and C  region and at the 3’ end, E  and 
3’RR respectively. There are promoters at 5’ of VH, D and CH genes. These cis-acting regulators 
collectively govern Ig gene expression. V(D)J rearrangement is also strictly controlled in a stage 
and cell-type specific manner by these cis-acting regulators, presumably by the accessibility 
control mechanism as discussed in section 1.3.6. In addition, these cis-elements also control the 
process of CSR and SHM. Rearrangements of the heavy and light chain gene segments generate 
recombined V(D)J genes coding for IgH and IgL chains. As a consequence of the DNA deletion 
during this process, cis-regulating elements (like promoters and enhancers) are brought together 
for function. RNA polymerase DNA binds to promoters to initiate mRNA synthesis. Enhancers 
enhance transcription levels of genes, often by binding trans-regulating factors (transcription 
factors) and bringing these to the promoter region to enhance transcription (189, 190). In 
addition to the “classic” function attributed to enhancers (to enhance gene transcription), these 
DNA enhancer sequences appear to have many other functions, as well (discussed below). The 
regulatory functions of these immunoglobulin enhancers are therefore essential to Ig expression 
as well as B cell development, and are not yet fully understood. 
1.9.1 Heavy chain intronic enhancer E  
E  is a cis-acting transcriptional enhancer lying in the intron region between the JH and C  
coding sequences of the Igh locus (Figure 1.2). It is a 1 kb fragment consisting of a core region 
(cE , 220 bp with enhancer activity) and two nuclear matrix attachment regions (MARs, 
facilitating cE  activity) flanking it (191-193). E has been shown to be essential for 
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transcription of Igh genes in early stage B cells of transgenic animals (192-194). E  has also 
been shown to be required for efficient heavy chain variable region (VH) gene assembly (78, 103, 
195). Targeted deletion of this enhancer region results in reduced D-to-JH, and VH-to-DJH 
recombination (78-80, 196). It is the cE , but not MARs, that is essential for promoting VHDJH 
recombination (78-80, 195, 196).  
A number of studies have shown that E  is active at the pro-B cell stage to enhance VH gene 
assembly (85, 197). Replacement of iE (the intronic enhancer of Ig  locus, Figure 1.3) with E  
leads to Ig  rearrangement in pro-B cells and absence of Ig  rearrangement in pre-B cells, 
suggesting E ’s specificity of controlling VHDJH recombination at the pro-B cell stage. Further 
investigation is warranted for the timing and mechanism of E ’s activity and function in Ig 
expression and B cell development. 
In previous studies, we circumvented the need for E in VH gene assembly to study its functions 
after this process. This was done using an E -deficient Igh
a
 allele with a pre-assembled heavy 
chain variable region gene B1-8VH knocked into the endogenous Igh locus (VH
a
, Figure 1.11). 
In the absence of E  cells with a pre-assembled VH gene progress to the pre-B cell stage and 
rearrange the light chain genes, and then eventually mature and populate the periphery. The 
feedback-inhibition of VH-to-DJH joining on the second Igh locus occurs at the same 
frequency/efficiency as in E -intact pre-B cells (as discussed in section 1.5, Figure 1.10). 
However, IgH allelic exclusion is compromised in the emerging immature B cells, suggesting a 
two-step process involved in allelic exclusion and E ’s function at the second “check-point” of 
this central mechanism to ensure B cell single specificity (146). In other words, E  serves as a 
mediator of the second “check-point” for allelic exclusion after feedback inhibition. In addition, 
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as a transcriptional enhancer, E  drives heavy chain gene expression in a cell-type specific 
manner in lymphoid cells (198-200). Deletion of E  resulted in half of the wild-type level of 
Ig expression in pre-B cells (146). We have proposed that E ’s role in positive selection at the 
pre-B to immature B cell transition is likely transcription-level dependent (146). 
Studies on E ’s role in somatic hypermutation (SHM) and class switch recombination (CSR) 
were first carried out also in the VH
a
 model. Both SHM and CSR took place on the VH
a
 allele, 
however, at a decreased rate. This decrease was transcription-independent. Instead, E ’s function 
in these two important processes for Ig modification is to assist recruitment of the SHM/CSR 
machinery to the Igh loci in cis (201). 
In general, a model of E ’s roles in regulating B cell development is that it promotes heavy 
chain variable region gene assembly, and then enhances the transcription of the newly assembled 
IgH gene, most importantly at the pre-B cell stage in the bone marrow. At the mature B cell stage 
in the periphery, E  serves to recruit the necessary machinery to the Igh locus and regulate its 
modification. 
1.9.2 3’ Regulatory Region (3’RR) of heavy chain locus 
There is a series of cis-elements located downstream of the C  region, the 3’ regulatory region 
(3’RR), consisting of DNase I hypersensitive sites. Lying away from the rearranged VH genes, 
the 3’RR enhances the IgH promoter activity over a long distance. These enhancers don’t 
influence VH gene rearrangement, but control class switch recombination (CSR) at later stages of 
B cell development (202, 203). It has been suggested that the enhancer reactivity of 3’RR 
activates transcription from promoters flanking the S regions of CH gene segments, and therefore, 
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regulates CSR (204, 205). In addition, 3’RR is proved to sustain high-level IgH gene 
transcription in Ig-secreting cells, even in the absence of Eµ (205-210). Loss of the 3’RR in Ig-
secreting cells had a dramatic effect on Ig transcription even when E remained on the affected 
allele (211, 212). These two findings led to the hypothesis that the role of Eµ in promoting IgH 
transcription could be supplanted by the 3’RR at the plasma-cell stage. Later studies have shown 
that the 3’RR reaches its highest activity and starts regulating Ig gene expression at immature 
and mature B cell stages, to ensure high levels of IgH expression starting from the immature B 
cell stage (213-215). Human c-myc gene expression, driven by hs3a-hs1,2-hs3b-hs4 (the four 
enhancers at the DNase I hypersensitive sites on murine Igh locus, Figure 1.2), were at low 
levels in pro-B and pre-B cells, but high levels in immature and mature B cells (214), supporting 
the notion that 3’RR has no or weak enhancer activity at the pro-B and pre-B cell stages. For this 
reason, E  is essential for IgH transcription in these early stage B cells. On the other hand, since 
Ig  is expressed at a much lower level in pro-/pre-B cells than in immature and mature B cells, 
3’RR might have a stronger enhancer activity than E  does, and is most active in late-stage B 
cells. 
1.10. Disorders of immune system 
1.10.1 Immunodeficiency 
The integrity of the immune system is essential for the body to defend against infections. If the 
immune system is missing or even compromised, then the host will be highly susceptible to 
pathogens, causing immunodeficiency diseases which are often fatal. Defects in immune system 
may occur in any component during any developmental stage. For example, there is humoral 
immune deficiency caused by defective B cells, plasma cells or antibodies; T cell deficiency 
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resulting in compromised cellular and humoral immune responses, and complement deficiency. 
Immunodeficiency may also result from reduced numbers of granulocytes, or absence of spleen 
function. The immunodeficiency can be inherited or acquired. Primary immunodeficiency is 
congenital, making the body highly susceptible to infections from infancy onward. Secondary 
immunodeficiency is acquired because of various immunosuppressive agents, such as drug 
treatment, malnutrition, or infection. Disturbed or inadequate development of the B cells 
therefore renders the host liable to immunodeficiency. Elucidation of the regulation mechanisms 
of B cell development is vitally important. 
1.10.2 Autoantibodies and their role in autoimmunity 
Failure to distinguish self-constituents from non-self allows an immune response against the 
body’s own cells, and this aberrant reaction is autoimmunity. B and T lymphocytes may express 
receptors with specificities to self-antigens during development. Self-tolerance is achieved 
through negative selection processes (apoptosis, receptor editing or anergy) that prevent the 
outgrowth of self-reactive lymphocytes. Abnormal regulation of these selection processes, or 
disruption by external factors may result in loss of self-tolerance. Autoantibodies are hallmarks 
for the humoral responses inappropriately directed against self-components, which can mount 
effective destruction against self-determinants. The first evidence of autoimmue disease due to 
continuous self-specific antigen and antibody interaction, was the identification of autoantibodies 
in glomerulonephritis patients (216). Systemic lupus erythematosus is another autoimmune 
disease in which the immune system attacks the hosts’ cells and tissues, resulting in 
inflammation and tissue damage. It is characterized by antibodies to dsDNA and/or nuclear 
proteins in the hosts (217). Although the correlation between autoantibodies and systemic 
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autoimmune disease is widely known, the contribution of autoantibodies to the autoimmune 
disease, as well as the defective regulatory processes that account for the pathogenesis remain to 
be elucidated. For example, subtle alterations in the signaling pathways that influence BCR 
responses to self-antigens may predispose an individual to autoantibody production and possibly 
autoimmune disease. Most of the currently known human autoimmune diseases result from both 
genetic factors and environmental effects, both of which collectively dysregulate the B cell 
functionality and thereby confer susceptibility to autoimmune diseases (218). In order to achieve 
a diverse population of B cells capable of producing high-affinity antibodies with no 
pathological autoreactivity, the development of B cell needs to be precisely regulated to avoid 
self-reactivity. Study of the negative selection and the regulatory mechanisms of autoreactive B 
cells is therefore, challenging and of great importance. New insight into abnormal survival of 
autoreactive B cells and the pathogenesis of autoimmunity is demanded.  
1.11. Aims of study 
To make a mature B cell population that produces a highly diverse antibody repertoire, which 
recognizes numerous foreign antigens but lacks anti-self reactivity, B cell development is 
regulated through intracellular signals propagated by B cell receptors (149, 156, 161, 162). 
Disruption of any element of the pre-BCR or BCR (the SLC, membrane Ig , Ig  or Ig ) or of 
the downstream signaling pathways of these receptors blocks B cell development, indicating that 
not only membrane expression but also the signaling capacity of these receptors are critical for 
the development and maintenance of the mature B cell population (161, 163, 164). 
Several different experimental models have suggested that the ligand-independent, constitutive 
(tonic or basal) signaling strength of the pre-BCR and BCR is directly proportional to their 
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membrane densities. Reduced receptor expression translates into diminished tonic signaling, 
impairing B cell maturation and skewing the development of B cell subsets (178, 219-223). In 
the current study, we explore the hypothesis that one role of the transcriptional enhancer E  is to 
ensure sufficient Ig  protein levels in pre-B and nascent immature B cells, and thus sufficient 
BCR density, to support positive selection into the immature B cell compartment. The following 
aims are to further characterize the defects associated with the absence of E  in the VH
a
 model, 
identify the changes in BCR signals, and test the effects of “allelic inclusion” on antibody 
production. Understanding the nature and extent of these defects (in development, BCR 
repertoire and BCR signaling) caused by expression of an E -deficient allele, will provide us 
with new insights into the mechanisms regulating B cell development. 
Aim 1. Study the effects of E -deficiency on early B lymphocyte development after VHDJH 
recombination. 
In previous studies, we circumvented the need for E  in VH assembly to study its functions after 
this process. To do this, we created an E -deficient Igh
a
 allele with a pre-assembled heavy chain 
variable region gene B1-8VH knocked into the endogenous locus (VH
a
, Figure 1.11). We found 
that, in pre-B cells, this allele was expressed at half the level of an identical but E -intact allele 
(VHEµ
a
), resulting in ~½ normal cytoplasmic Ig  levels (146). We propose that this reduction in 
Ig expression causes a decrease in the strength of signals emanating from newly emerging 
BCRs, which should result in signals insufficient for positive selection and thereby an inefficient 
transition from pre-B to immature B cell stage. 
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1a. To test this hypothesis, we will look at the efficiency with which pre-B cells differentiate into 
immature B cells. Our previous study suggests that this transition should be impaired if we 
analyze the bone marrow B cell subpopulations in mice heterozygous or hemizygous for the 
VH
a
 allele, with comparison to the corresponding VHE
a
 mice. Steady-state levels of pre-B and 
immature B cell subsets from the bone marrow of mice carrying the VH
a
 allele will be 
examined.  
1b. To completely study the effects of E -deficiency on B lineage cell development, we will also 
take note of B cell subsets other than pre-B and immature B cell stages, including transitional 
stage B cells in the bone marrow and mature B cells in the spleen. In this way, the rate at which 
cells differentiate from one compartment to the next will be described. 
Aim 2. Test the hypothesis that E  ensures Ig  levels and thereby amplifies BCR signal 
strength for the positive selection of pre-B cells into immature B cell stage. 
In this aim, we seek to test the relationship between E  deletion and pre-BCR/BCR signal 
strength. The differences between pre-BCR/BCR signals that can and cannot support early B cell 
differentiation will be examined.  
2a. We will compare the signal strengths of pre-BCRs dependent solely on  expressed from the 
VH
a
 and VHEµ
a
 alleles, respectively. Since the Ig level in pre-B cells of VH
a
 mice is ~½ that 
of VHE
a
 mice, we would expect impaired B1-8 H-chain pre-BCR signals in the absence of E . 
We will test this hypothesis by measuring phosphorylation of downstream targets in the pre-B 
cells. 
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2b. Tonic BCR-signals in VH
a
 and VHE
a
 immature B cells will also be compared, to explore 
the relationship between E  deficiency and BCR signal strength.  
Aim 3. Test the contribution of light chain editing (i.e. light chain gene sequence) in the 
development of B cells expressing the E -deficient allele. 
We have evidence that the E -deficient allele is posing problems at the pre-B to immature B cell 
transition from our analysis of mature, splenic B cells that expressed Ig  from only the E -
deficient IgH allele (VH
a
 single-producers). These cells have undergone extensive light-chain 
editing, a process that takes place in pre-B cells transitioning to the immature B cell stage (146, 
179). We suggest this is a sign of weak BCR signals (low Ig ) insufficient for a prompt “turn-off” 
of the recombination machinery (the recombination-activating genes RAG-1 and RAG-2) and for 
progression to the immature B cell stage.  
3a. We postulate that the extensive receptor editing, in response of VH
a
-B cells to reduced BCR 
signals, serves to create an IgH/IgL combination with superior signaling properties to drive the 
pre-B to immature B cell transition in the absence of E , through formation of a BCR with 
higher stability and/or a specificity that can ratchet up the signals above the threshold required 
for the pre-B to immature B cell transition. As a test of this hypothesis, we ask whether 
providing the E -deficient B cells with a pre-assembled V knock-in gene (we use 3-83V  gene 
for the current study) would affect the rate of pre-B to immature B cell transition, to assess the 
contribution made by light chain editing (i.e. light chain sequence) to overcome the low  levels.  
3b. We found a breach of allelic exclusion in VH
a
/WT
b
 mice, with >20% splenic B cells 
expressing two IgH alleles as “double-producers”, which were not found in VHE
a
/WT
b
 mice. 
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Determining whether the V  knock-in light chain affects the outgrowth of these double-
producers should also provide insight into the cell selection processes that explain the 
mechanism of allelic exclusion. Our hypothesis is that the BCR signal is the determining factor 
in whether the second “check-point” for allelic exclusion is breached (previously described as an 
E -dependent “check-point” at the pre-B to immature B cell transition) 
Besides bi-allelic expression of the IgH chains, receptor editing is another means by which the 
E -deficient B cell development could be rescued. So the level of light chain editing 
(downstream J  usage and/or  chain expression) will be analyzed in the VH
a
/3-83 mice. 
Aim 4. Test the long-held notion that allelic “inclusion” supports the development of 
autoreactive B cells. 
An early prediction made by Burnet, when describing his theory of clonal immature B cell 
selection, was that cells with receptors of more than one specificity would be at risk of co-
expressing both protective and autoreactive receptors. We will test cells expressing both the 
VH
a
 and the wild type IgH alleles (double-producers), for their secretion of autoreactive 
antibodies. 
4a. Preliminary anti-nuclear antibody (ANA) assay of sera from VH
a
/WT
b
 mice indicated a 
propensity of autoreactivity in the animals expressing double-producers. Matched strains of mice 
will be compared for the sera reactivity to certain auto-antigens (e.g. dsDNA). 
63  
4b. Double-producers and single-producers from VH
a
/WT
b
 mice will be directly analyzed for 
autoantibody (anti-dsDNA antibody) secretion in vitro, to determine the origin of the 
autoreactivity. 
The results of these studies, in large part, have now been published (Peng, C. and L. A. Eckhardt. 
2013. Role of the Igh Intronic Enhancer E  in Clonal Selection at the Pre-B to Immature B Cell 
Transition. The Journal of Immunology 191: 4399-4411). 
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Chapter 2: Materials and Methods 
2.1. Mice 
All mice in this study were maintained under pathogen-free conditions in the Animal Facility at 
Hunter College, City University of New York. All protocols were reviewed and approved by 
Hunter College Institutional Animal Care and Use Committee. 
2.1.1. B1-8VH knock-in mice 
The heavy chain variable region gene knock-in mice VHEμ
a
/VHEμ
a
, with a pre-assembled VHDJH 
gene segment (B1-8VH) on both the endogenous Igh loci, were originally described as B1-8i 
mice, and supplied by Dr. K. Rajewsky’s lab (CBR Institute for Biomedical Research, Boston, 
MA) (144). The B1-8VH gene represents a recombined Ig variable region derived from a 4-
hydroxy-3 nitrophenylacetyl binding antibody (B1-8). The B1-8VH “knock-in” gene replaces the 
endogenous DQ52 and the JH gene segments on the Igh locus. There is a silent point mutation in 
codon 92 of the B1-8VH gene, which inactivates the internal heptameric RSS, preventing 
endogenous VH replacement such that the stability of this gene segment is increased.  
The VHΔ
a
/VHΔ
a
 mouse line carries the same B1-8VH knock-in gene but with the intronic 
enhancer E removed from both the Igh loci (146). Both VHEμ
a
 and VHΔ
a
 alleles in this study 
encode a allotype Ig proteins. VHEμ
a
/VHEμ
a
 and VHΔ
a
/VHΔ
a
 homozygous mouse strains were 
crossed to C57BL/6J mice (described as WT
b
/WT
b
 mice, The Jackson Laboratory, Bar Harbor, 
ME, stock#000664) for 10 to 13 generations to make congenic VHΔ
a
/WT
b
 and VHEμ
a
/WT
b
 
heterozygous offspring (Figure 1.11). The IgH allele of C57BL/6J mice (WT
b
) encodes b 
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allotype Ig proteins. In some cases, the heterozygous mice were intercrossed and the offspring 
were analyzed to further eliminate the variations of the genetic background. 
2.1.2. JH mice 
The JH/ JH mice lack both E  and the JH gene segments on the Igh locus, precluding VHDJH 
recombination (224) (The Jackson Laboratory, B6.129P2-Igh-J
tm1Cgn
/J; stock#002438). These 
mice are not able to produce antibodies and hence no functional B cells. They were mated to 
VHEμ
a
/VHEμ
a
 and VHΔ
a
/VHΔ
a
 mice to generate VHEμ
a
/ JH and VHΔ
a
/ JH hemizygous offspring 
(Figure 2.1). B cell development in these mice depends entirely on the B1-8VH knock-in allele, 
with or without E VHEμ
a
 or VHΔ
a
 allele, respectively). 
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Figure 2.1: Diagram of Igh loci of hemizygous B1-8VH knock-in mice, VH
a
/ JH. 
B1-8VH is a pre-assembled VHDJH gene that is knocked into the Igh locus, replacing the DQ52 
and the JH gene segments. Shown in picture is the VH
a
 allele, with the intronic enhancer E  
removed from the locus. E and JH genes are deleted from the Igh loci of JH/ JH mice. Shown 
in the bracket are genes deleted on the JH locus, prohibiting VHDJH recombination and therefore 
Ig expression from this allele. 
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2.1.3. RAG1-/- mice 
RAG1 genes were deleted on both chromosomes of RAG1
-/-
 mice (225) (The Jackson Laboratory, 
B6.129S7 RAG1 <TM1MOM>/J; stock#002216). They are immunodeficient as they lack both 
mature B and T lymphocytes, due to the inability to assemble the BCR and TCR variable region 
genes. VHEμ
a
/VHEμ
a
 and VHΔ
a
/VHΔ
a
 mice were mated with RAG1
-/-
 mice on the C57BL/6J 
background, resulting in VHEμ
a
/WT
b
 RAG1
-/-
 and VHΔ
a
/WT
b
 RAG1
-/-
 progeny. B cell 
development in these progeny stalls at the pre-B cell stage because the cells cannot undergo light 
chain gene rearrangements without Rag1 protein.  
2.1.4. 3-83V  knock-in mice 
The light chain variable region (VL) gene knock-in mice, 3-83 /3-83 , with the pre-assembled 3-
83V  knock-in gene on both the kappa light chain loci, replacing the endogenous J 1 and J 2 
gene segments, were supplied by Dr. R. Pelanda (Integrated Department of Immunology, 
National Jewish Health, Denver, CO). A previous study showed that the B1-8VH/3-83V  
combination yields a B cell receptor (BCR) with innocuous specificity (226) (Figure 2.2).  
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Figure 2.2: Diagram of Igh and Ig  loci of B1-8VH and 3-83V  double knock-in mice, 
VH
a
/3-83 . 
One heavy chain locus with the pre-assembled B1-8VH gene is shown on top: VH
a
, encoding 
Ig
a
 proteins; Shown below it is one light chain locus with the pre-assembled VL gene: 3-83V , 
encoding 3-83 Ig  proteins. 
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2.2. Preparation of  DNA 
2.2.1. Isolation of genomic DNA 
Each mouse tail piece at about 0.5 cm was incubated in 500 l tail lysis buffer (100 mM Tris-
HCl, 5 mM EDTA, 200 mM NaCl and 0.2% SDS) with 20 l proteinase K (Sigma-Aldrich 
Cat.#P6556, 10 mg/ml in dH2O stored at -20 ºC) at 56 ºC overnight. Then the genomic DNA 
from the tails was isolated by phenol/chloroform extraction using the Phase Lock Gel
TM
 (PLG, 5 
Primer Cat.#2302830), according to the manufacturer’s protocol. Extracted DNA was dissolved 
in TE (10 mM Tris pH 7.6, 1 mM EDTA) buffer at 37 ºC for 2 hours and stored at 4 ºC for 
further analysis. 
2.2.2. Purification of calf thymus double-stranded DNA (dsDNA) 
250 mg of calf thymus DNA (Sigma-Aldrich, Cat.#D1501-1G) was added to 40 ml TE buffer. 
The solution was stirred on the rocking platform for 2-3 days for the DNA to dissolve. DNA 
solution was split to 10 ml aliquots and fragmented by sonication in a beaker with ice for 1.5 
minutes. Equal volumes of TE equilibrated 1:1 phenol/SEVAG (phenol: chloroform: isoamyl 
alcohol = 25: 24: 1) solution (10 ml) were added to each aliquot (10 ml), and mixed by inversion. 
The mixtures were centrifuged at 14000 rpm for 5 minutes and DNA was in the upper layer. 
Phenol/SEVAG extraction was repeated using the upper layer DNA solution. 1/10 (1 ml) the 
volume of the original solution (10 ml) of 3 M NaOAc was then added and mixed with the DNA 
solution by inversion. And then equal volume (10 ml) of 100% ethanol was added and mixed by 
inversion. After 5 minutes of centrifugation at 1400 rpm, the DNA was in the precipitate and the 
supernatant discarded. 70% ethanol was used to wash the DNA pellet. Dried DNA pellets were 
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dissolved in the original volume (10 ml) of TE buffer, and 0.01% sodium azide was added. DNA 
segments were tested by agar gel electrophoresis and stored at 4 ˚C. DNA solution was filtered 
through a 0.45 m filter before use, and dsDNA came through the filter whereas the ssDNA was 
bound to the filter. 
2.3. Genotyping mice 
VHEμ
a
 and VHΔ
a
 alleles were detected by polymerase chain reaction (PCR) using the genomic 
tail DNAs, as were wild-type (germline configuration) Igh (WT
b
), Ig , 3-83 , wild-type RAG1, 
and RAG1-deletion loci (described below). Mice sera were analyzed by ELISA for IgM
a
 and 
IgM
b
 as one indication of the genotype of the Igh loci (VHEμ
a
 orVHΔ
a
 versus WT
b
, see section 
2.7).  
2.4. Polymerase Chain Reaction (PCR) 
Genotyping PCRs were performed with HotStar Plus Taq polymerase (Qiagen, Cat.#203646) 
according to the manufacturer’s protocol. The following primer pairs were used to amplify the 
tail-tip genomic DNA: 
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Table 2-1: Primers used to amplify genomic DNA for genotyping. 
a, b
The J 1 and J 2 region is missing on the 3-83V  knock-in allele. 
c, d, e
RAG1 gene primers: 
http://jaxmice.jax.org/protocolsdb/f?p=116:2:4183119992152012::NO:2:P2_MASTER_PROTO
COL_ID,P2_JRS_CODE:329,002216 
Primer Locus Sequence 
Primer 
number 2 
(146) 
Within the 3’ homology region of B1-
8VHΔ
a
; nucl. 136031-136054, 
GenBank AC_073553 
5’-CAGAGGGAGTTCACACAGAGCATG-3’ 
Primer 
number 4 
(146) 
Immediately 5’ of the leader exon of 
B1-8VH; nucl. 312629-312655, 
GenBank BN_000872 
5’-
TCTTTACAGTTACTGAGCACACAGGAC-
3’ 
Primer E3HR 
(201) 
Within the 3’ homology region of 
targeting vector to generate B1-8i 
mice (144); complementary to nucl. 
134588-134613, GenBank 
AC_073553 
5’-CTCCACCAACACCATCACACAGATTC-
3’ 
JH4f  (146) Within JH4; nucl. 134365-134389, 
GenBank AC_073553 
5’-CTATGGACTACTGGGGTCAAGGAAC-
3’ 
VDJ junction 
primer (146) 
The unique VHDJH junction sequence 
of B1-8VH 
5’-CGCAAGATACGATTACTACGG-3’ 
Wild-type 
Ig (forward 
Between J 1 and J 2 of the WT  
locus; nucl. 39919879-
5’-GATTCTGGCACTCTCCAAGG-3’ 
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primer) 39919898,GenBank NT_039353 
Wild-type Ig  
(reverse 
primer ) 
Between J 2 and J 3 of the WT  
locus; complementary to 
nucl.39920274-39920293,GenBank 
NT_039353 
5’-CCAACCTCTTGTGGGACAGT-3’ 
3-83V  
knock-in 
(forward 
primer)
a
 
Upstream of 3-83V  coding 
sequences; within the 3-83V  
insertion, which replaces J 1-J 2 on 
the WT  locus (227) 
5’-
GCGGCCGCACACTATATTTTCCTCCTTC-
3’ 
3-83V  
knock-in 
(reverse 
primer)
b
 
3’end of 3-83V  coding sequences; 
within the 3-83V  insertion, which 
replaces J 1-J 2 on the WT  locus 
(227) 
5’-
GTCGACAACACACAACAAAGAACAAC-3’ 
WT-RAG1-F
c
 RAG1 forward primer; nucl. 
42522471-42522490, GenBank 
NT_039207 
5’-GAGGTTCCGCTACGACTCTG–3’ 
WT-RAG1-
R
d
 
Common reverse primer for RAG1 
and RAG1-deletion mutant; 
complementary to nucl. 42522016-
4252235, GenBank NT_039207 
5’-CCGGACAAGTTTTTCATCGT–3’ 
dRAG1-F
e
 Forward primer for RAG1-deletion 
mutant 
5’-TGGATGTGGAATGTGTGCGAG–3’ 
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Primers number 4 and E3HR generate an 834 bp product from only the VHEμ
a
 allele, but not 
other IgH alleles. Primer number 2 and VDJ junction primer are specific for the VHΔ
a
 allele and 
generate a 387 bp product. JH4f and primer E3HR generate a 249 bp product from only the wild 
type Igh (WT
b
) locus. Wild-type Ig  primers anneal to wild type kappa locus and generate a 415 
bp product. 3-83V knock-in gene primers anneal to 3-83V gene and generate a 1.1 kb product. 
Primers WT-RAG1-F and WT-RAG1-R generate a 474 bp product from the wild type RAG1 
locus, whereas WT-RAG1-R and dRAG1-F generate a 530 bp product from the RAG1 deficient 
mutant. All primer pairs are specific for their designated genes, and don’t generate a detectable 
product from other gene loci under the reaction conditions.  
2.5. Gel electrophoresis in agarose gels 
Agarose gel electrophoresis was used for the detection of DNA products of the PCR. 1% agarose 
was dissolved in the electrophoresis buffer TAE (Tris/Acetate/EDTA). DNA molecules are 
negatively charged in the TAE buffer because of the ionized phosphate residues. Once the 
electric field is provided, DNA fragments move to the positive electrode at different rates. The 
smaller the fragment is, the faster it moves in the gel. In most cases of this study, the gel 
electrophoresis was performed at 110 V. DNA molecules in the gel were stained with ethidium 
bromide (EtBr), which intercalates to DNA and fluoresces under the UV light. By comparing to 
DNA markers, the sizes of the DNA products were estimated. 
2.6. Real-time reverse transcriptase (RT) PCR 
To quantify RAG2 and germlineIg  transcripts in pre-B cells by the quantitative real time RT-
PCR, bone marrow B cells were first enriched by positive selection for B220
+
 cells using B220 
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MicroBeads kit (Miltenyi Biotech). Total RNA was extracted by RNeasy mini-prep kit (Qiagen, 
Cat.#74104) following the manufacturer’s protocol, and the RNA products were treated with 
RNase free DNase (Qiagen, Cat.#79254) to remove genomic DNA. RNA solutions were 
adjusted to 100 g/ml in RNase-free water.  
One-step, real-time RT-dependent PCRs were performed with the isolated RNAs, using the 
QuantiFast SYBR Green RT-PCR kit (Qiagen, Cat.#204154). Primers for κ germline transcripts 
(0.8 kb (228); GenBank NT_039353) were 5′-
CAGTGAGGAGGGTTTTTGTACAGCCAGACAG-3′ (forward, immediately upstream of J 1; 
nucl. 39919702-39919732) and 5′-CTCATTCCTGTTGAAGCTCTTGACAATGGG-3′ (reverse, 
within C ; complementary to nucl. 39923911-39923940); Primers for detecting RAG2 mRNA 
were from Qiagen (QuantiTect Primer Assay, QT00253414). Samples were normalized using 
primers for mRNA from the house keeping gene hgprt1 (hypoxanthine/guanine phosphoribosyl 
transferase; QuantiTect Primer Assay QT00166768). PCR reactions were performed on the 7500 
Real-Time PCR System (Applied Biosystems) at the biology department of Hunter College, 
CUNY. Data were analyzed with the software supplied by Applied Biosystems (User bulletin #2). 
Reverse-transcriptase negative controls were included to exclude the possibility of genomic 
DNA contamination. 
2.7. Enzyme-Linked Immunosorbent Assay (ELISA) 
Antibodies expressed from the VH knock-in (IgM
a
) and/or wild-type (IgM
b
) IgH alleles were 
detected and distinguished in the sandwich-type ELISA, using allotype-specific antibodies. 
Biotinylated mouse anti-mouse IgM
a
 antibody (BD Biosciences, Cat.#553515) and biotinylated 
mouse anti-mouse IgM
b
 antibody (BD Biosciences, Cat.#553519) were used to detect a and b 
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allotype IgM, respectively. Blood samples were collected from VHEμ
a
/VHEμ
a
, VHΔ
a
/VHΔ
a
; 
VHEμ
a
/WT
b
, VHΔ
a
/WT
b
; VHEμ
a
/ JH, VHΔ
a
/ JH, and C57BL/6J mice. Sera samples were 
prepared by spinning blood samples at 12,000 rpm for 5 min and stored at 4 ˚C with 0.1% NaN3 
in PBS.  
2.7.1. Quantification of immunoglobulin 
For IgM
a
 and IgM
b
 proteins: For both qualitative and quantitative ELISAs, 96-well 
immunoplates (NuncMaxisorp, Thermo Scientific) were coated with rat anti-mouse IgM 
antibody (BD Biosciences, Cat.#553405) at 4 ˚C overnight. Plates were then blocked with 
blocking buffer (3% bovine serum albumin, BSA; 0.1% NaN3 in phosphate-buffered saline, PBS) 
at room temperature (RT) for one hour. To quantify IgM
a
 and/or IgM
b
, mouse sera or culture 
supernatants were diluted and each dilution was analyzed in duplicate. After applying mouse sera 
or culture supernatants and one hour incubation at RT, plates were washed 3 times with washing 
buffer (1x PBS, 0.05% Tween-20). 100 l per well 1 g/ml biotinylated anti-allotype antibodies 
were then added to detect a or b allotype IgM. After one hour incubation at RT, plates were 
washed 3 times and 100 l 1:1000 diluted streptavidin-horse radish peroxidase (SA-HRP; BD 
Biosciences, Cat.#554058) was added to each well to detect the anti-allotype antibodies. After 
one hour incubation at RT, plates were washed 3 times and ABTS (Southern Biotech, Cat.#0401-
01) was applied as the substrate for HRP. Plates were read at 405 nm, using the PowerWave HT 
microplate spectrophotometer (BioTek, Winooski, VT), and data were analyzed by the software 
Gen5 (BioTek). A titration curve for each assay was generated with purified mouse 
immunoglobulin of the relevant Ig allotype. OD405 of all tested samples was in the linear range 
of the assay.  
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2.7.2. Test for anti-dsDNA antibodies 
For anti-dsDNA antibody: Detection of IgM
a
 or IgM
b
 anti-dsDNA antibodies by ELISA was 
performed as previously described by others (229). Briefly, calf thymus DNA (Sigma-Aldrich, 
Cat.#D1501) was sonicated and purified by phenol extraction, and then was diluted to 100-150 
g/ml in PBS and filtered through a 0.45 m microcellulose filter (Millipore, Bedford, MA) to 
remove ssDNA. 100 l dsDNA solution was added to each well of the Immulon-2 HB 96-well 
plate (Dynatech, Chantilly, VA). Plates were dried for 48 hours at 37 ˚C and blocked with 3% 
BSA in PBS (pH 7.4) for one hour at room temperature. Culture supernatant or diluted sera 
samples from mice of various genotypes were added and incubated for two hours at 37 ˚C. Wells 
were then washed with 0.05% Tween-20 in PBS. Binding of IgM
a
 molecules to dsDNA was 
revealed with biotinylated mouse anti-mouse IgM
a
 antibody and streptavidin-HRP at 405 nm. A 
purified mouse monoclonal IgM
a
 anti-dsDNA antibody, kindly provided by Dr. L. Spatz 
laboratory (Department of Microbiology and Immunology, Sophie Davis School of Biomedical 
Education, City College of New York), was also serially diluted by two-folds beginning with a 
concentration of 0.5 g/ml, and was used to generate a standard curve. OD405 of all samples 
analyzed was in the linear range of the standard curve. The relative levels of IgM
a
 or IgM
b
 anti-
dsDNA antibodies were normalized to IgM
a
 or IgM
b
 protein levels (total amount of IgM
a
 or 
IgM
b
 in each serum sample was quantified by ELISA as described above). Consistency of all 
ELISA results was confirmed by 3 repeated assays of each sample. 
2.8. B cell isolation and in vitro cell culture 
Single-cell suspensions were prepared from the bone marrow and spleen in cold RPMI-1640 
media (Mediatech, Inc. Cat.#17-104-CI) containing 5% fetal bovine serum (FBS, Thermo Fisher 
77  
Scientific, Cat.#SH30070.03). Erythrocytes were lysed by ACK lysis buffer (0.15 M NH4Cl, 10 
mM KHCO3, and 0.1 mM EDTA, pH 7.4). In some cases, B lineage cells were isolated by 
magnetic cell sorting. Bone marrow B lineage cells were positively selected with the MACS 
B220 MicroBeads kit (Miltenyi Biotech, 130-049-501), and splenic B cells were enriched by 
negative selection of CD43-expressing cells with the CD43 microbeads (B cell isolation kit, 
mouse, Miltenyi Biotech, 130-090-862). For some experiments, a FACSVantage (BD 
Biosciences) was used to identify and separate IgM
a+b+
 and IgM
a+b-
 cells before placing these 
separate populations into culture (described below). 
For lipopolysaccharide (LPS)-stimulated cultures, splenic B cells isolated from 10-week-old 
mice were cultured at 37 ºC, 5% CO2, for 7 days starting at a density of 5 x 10
5
 cells/ml in RPMI 
full media (RMPI-1640, supplemented with 20% FBS; 50 M -mercaptoethanol, Life 
Technologies, Cat.#21985-023; 2 mM L-glutamine, Life Technologies, Cat.#25030-081; 100 
U/ml penicillin, 100 g/ml streptomycin, Life Technologies, Cat.#15140-122; 100 M non-
essential amino acids, Life Technologies, Cat.#11140-050) with 25 g/ml LPS (Escherichia coli, 
serotype 055:B5; Sigma-Aldrich, Cat.#L6511). Cell culture supernatants were collected and 
assayed by ELISA for the presence of IgM
a
 or IgM
b
 antibodies to dsDNA and for the 
quantification of total IgM
a
 or IgM
b
 antibodies. 
2.9. Flow cytometry 
2.9.1. Cell analysis 
Single cells were stained for surface and intracellular molecules by standard procedures. In 
general, 1x10
6
 cells were incubated with the corresponding monoclonal antibodies in FACS 
78  
staining buffer (1x PBS, 5.6 mM glucose, 0.1% BSA, and 0.1% NaN3), at 4 C for 20 min. 
Monoclonal antibodies from BD Biosciences included: fluorescein-isothiocyanate (FITC) 
conjugated anti-mouse CD3  (BD553061), anti-mouse IgM (BD553408), anti-mouse IgM
a
 
(BD553516), anti-mouse Ig (BD550003), anti-mouse CD23 (BD553138); phycoerythrin (PE) 
conjugated anti-mouse IgM
b
 (BD553521), anti-mouse CD43 (BD553271), anti-mouse CD21 
(BD552957); allophycocyanin (APC) conjugated anti-mouse B220 (BD553092). Biotin-
conjugated antibodies were revealed with streptavidin-PE (BD554061). Monoclonal antibodies 
from Southern Biotech included: PE conjugated anti-mouse Ig  (Cat.#1175-09), and biotin 
conjugated anti-mouse IgD (Cat.#1120-08). Cells were washed in FACS washing buffer (1x PBS, 
5.6 mM glucose, and 0.1% NaN3) after staining. Dead cells were excluded from analysis by 
propidium iodide staining.  
For cytoplasmic Ig , Ig  and Ig  staining, bone marrow cells were isolated and incubated with 
an antibody to B220 (and/or antibodies to other cell surface markers, as appropriate for the 
experiment to identify the pre-B, and/or immature B cell subsets). Cells were then fixed and 
permeabilized using Cytofix/Cytoperm (BD Biosciences, Cat.#554714) buffer at RT for 20 min. 
Intracellular Ig  was stained with FITC conjugated anti-mouse IgM (BD553437), and 
intracellular Ig  and Ig  was revealed by antibodies described above.  
Phosphoflow staining: To detect the phosophorylation status of intracellular signaling molecules, 
freshly isolated single-cell suspensions (1 x 10
6
 ~ 5 x 10
6
 bone marrow cells) were surface 
stained with anti-B220-APC (in some cases also anti-sIgM-PE, BD553409 or anti-sIgM-FITC, 
BD553408), and then washed with PBS and resuspended in pre-warmed (37°C) RPMI 1640 
medium (up to 5 x 10
6
 cells/ml), incubated for 5 minutes. Sodium pervanadate (10 l per 1 ml of 
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cell suspension) was then added immediately into the cell suspension to a final concentration of 
60 µM for 5-minute incubation at 37 °C. 
Sodium pervanadate inhibits intracellular tyrosine phosphatases, which results in accumulation 
of tyrosine phosphorylation (and/or hyperphosphorylation of tyrosine kinases). It has been used 
to analyze the relative amount of tyrosine-phosphorylated protein, which is an indicator of the 
activity of the signaling pathways (158, 159, 230, 231). Sodium pervanadate was prepared by 
mixing 1 ml of 20 mM sodium orthovanadate (Na3VO4, pH 10.0, diluted in water) and 330 l of 
30% H2O2 at room temperature for 5 minutes, to yield a 6 mM pervanadate solution with the 
remaining H2O2, and was used at a final dilution of 1:100 (or diluted to 100 M in RPMI to 
make a 2x solution). 
Cells were then washed with PBS, fixed and permeabilized with Cytofix/Cytoperm buffer and 
incubated with anti-phosphotyrosine antibody (BD558008), anti-pErk (BD612592), anti-pSyk 
(BD560081) or one of the corresponding isotype-matched, control antibodies with irrelevant 
specificity, at 4 °C for 30 min. For phosphorylated Syk: the mouse anti-Syk antibody (I120-772) 
is specific for the mouse Syk phospholytation site tyrosine 342 (pY342). For phosphorylated Erk: 
the mouse anti-Erk1/2 monoclonal antibody (20A) recognizes the phosphorylated threonine 203 
and tyrosine 205 (pT203/pY205) residues in murine Erk1, and the T183/Y185 in murine Erk2. 
For phosphorylated total tyrosine: the mouse anti-phosphotyrosine antibody (PY20) detects all 
phosphorylated tyrosine residues. 
For all flow-cytometry experiments, cell analysis was on a FACSCalibur (BD Biosciences), data 
were acquired with CellQuest (FACS instruments), and data were further analyzed with FlowJo 
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software (Tree Star, Inc.). Lymphocytes were gated according to side and forward scatter, and 
further gates were applied as described in individual experiments.  
2.9.2. Cell sorting 
Cell sorting of IgM
a+b+
 double-positive, and IgM
a+b-
 single-positive splenic cells was done with 
the FACSVantage
TM
 (BD Biosciences). Cells were first enriched using the MACS B cell 
negative magnetic selection kit (described above), and then surface stained with anti-B220-APC, 
anti-IgM
a
-FITC and anti-IgM
b
-PE for sorting by flow cytometry. 
2.10. Statistical analysis 
Statistical tests for differences among the mouse lines were performed with GraphPad Prism 5 
software. Student’s unpaired two-tailed t-test was used to assess the statistical significance of the 
differences. Differences with a p-value of less than 0.05 were considered significant.  
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Chapter 3: Results 
The results of these studies, in large part, have now been published (Peng, C. and L. A. Eckhardt. 
2013. Role of the Igh Intronic Enhancer E  in Clonal Selection at the Pre-B to Immature B Cell 
Transition. The Journal of Immunology 191: 4399-4411). 
3.1. E -deficient (VH
a
) B cells have impaired pre-B to immature B cell transition 
 Immature B cell compartment is diminished in the bone marrow of E -deficient mice 
We previously described two strains of mice in which a pre-assembled heavy chain variable 
region gene (B1-8VH) had been inserted into the endogenous Igh
a
 locus, either leaving the 
intronic enhancer E  intact (VHE
a
), or deleting it VH
a
(described in chapter 2, Figure 1.11) 
(146) Mice heterozygous for the E -deficient allele (VH
a
WT
b
) showed a striking defect in 
allelic exclusion. This was not due to a defect in feedback inhibition of DNA rearrangement on 
the wild-type allele (this occurred normally, as in the VHE
a
WT
b
 mice), but instead reflected a 
defect at a second “check-point” that operates at the pre-B to immature B cell transition 
(described in chapter 1) (146). Further evidence that the E -deficient allele was posing problems 
at this transition came from an analysis of mature, splenic B cells that expressed Ig  from only 
the E -deficient allele. These cells had undergone unusually high levels of light-chain editing, a 
process that takes place in pre-B cells transitioning to the immature B cell stage (146). This 
finding, together with the fact that the E -deficient allele produced Ig  at ½ normal levels in pre-
B cells, led us to propose that absence of E  in an otherwise functional IgH gene, results in 
emerging BCRs that cannot achieve the density required to signal “positive selection” into the 
immature B cell compartment.   
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To further test this hypothesis in the current study, we compared B cell subsets in the bone 
marrow of B1-8VH knock-in heterozygous mice that retained (VHE
a
WT
b
) and lacked 
E VH
a
WT
b
). Because of the B1-8VH knock-in heavy chain gene, B cells largely bypass the 
pro-B cell stage (with no need for VHDJH assembly), rapidly progressing to the pre-B cell stage 
for light chain rearrangement. Antibodies to cell surface markers including anti-B220, anti-IgM 
and anti-IgD were used to identify pro- and pre-B cells (B220
+
IgM
-
IgD
-
), immature B cells 
(B220
+
IgM
+
IgD
-
), and mature, recirculating B cells (B220
+
IgM
+
IgD
+
). Wild-type C57BL/6J 
(WT
b
/WT
b
) mice were analyzed as a control, whose B220
+
IgM
-
IgD
-
 subset includes not only 
pre-B cells, but also pro-B cells undergoing heavy chain variable region (VH) gene 
recombination. As shown in Figure 3.1A, the immature B cell compartment in VH
a
WT
b
 mice 
(12.18% of the total B220
+
 BM B cells) was ½ the size of that in VHE
a
WT
b
 (24.80%) and 
WT
b
/WT
b
 (22.63%) mice. Although the majority (~90%, (146)) of immature B cells in the 
VH
a
WT
b
 mice express only the VH
a
 allele as Ig heavy chain (IgH) “single-producers”, there is 
still possibility of developmental “rescue” by co-expressing the WTb allele as IgH-“double-
producers”, which may compensate for the loss of E  on one of the IgH alleles and drive these 
~10% cells through the pre-B to immature B cell transition at a normal efficiency. We therefore 
next examined the B cell subsets in the “hemizygous” mice where B cell development is entirely 
dependent upon the B1-8VH knock-in loci. This was done by making the VHE
a
 and VH
a
 alleles 
heterozygous with an allele that lacked the JH gene segments ( JH; no VH gene assembly 
possible). As shown in Figure 3.1B, the immature B cell compartment in VH
a
JH mice was 
also ½ that of the VHE
a
JH mice (13.51% versus 23.54%). Data from multiple mice of these 
and the VHE
a
WT
b
, VH
a
WT
b
 and WT
b
/WT
b
 genotypes were quantified in the bar graphs of 
Figure 3.1C. In all cases, the ratio of E -deficient pro-/pre-B to immature B cells was about 
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twice that of E -intact ones, demonstrating that presence of the VH
a
 allele resulted in a less 
efficient transition from the pre-B to immature B cell stage.  
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Figure 3.1: Immature B cell compartment is diminished in VH
a
/WT
b
 and VH
a
/ JH mice.  
A. Representative flow-cytometry plots of bone marrow cells gated for B220+ (B-lineage cells) 
and analyzed for IgD and IgM surface expression: mature B cells (IgD
+
IgM
+
), immature B 
cells (IgD
-
IgM
+
), pro-B+pre-B cells (IgD
-
IgM
-
). Gates and percentage cells in gates are 
indicated (% calculated relative to total B220
+
 cells). VH
a
/WT
b
 = heterozygous for the wild-
type (Ig
b
) allele and the E -deficient allele with B1-8VH knock-in; VHE
a
/WT
b
 differs from 
VH
a
/WT
b
 only by virtue of the presence of E  on the B1-8VH knock-in allele. Both of the 
knock-in lines are on the C57BL/6J background; WT
b
/WT
b
 = normal C57BL/6J mouse as 
control.   
B. Representative flow-cytometry plots of bone marrow B-lineage cells from hemizygous VH 
knock-in mice (VHE
a
/ΔJH and VH
a
/ΔJH). Since the allele lacking the JH region (ΔJH) 
cannot assemble a VH gene, the “knock-in” allele is effectively “hemizygous”. Analyses as in 
A. 
C. Quantification of flow-cytometry data from the indicated numbers (n=) of mice of each 
genotype. Genotypes explained in A and B above. Ratios of (pro-B + pre-B) to immature B 
cells are compared (thereby leaving aside comparisons of re-circulating, mature B cells). 
Animals were age-matched (3-4 months). Error bars indicate Standard Deviation (SD); p-
values for differences in means were determined by two-tailed t-test obtained (GraphPad 
Prism 5). 
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To rule out the possibility that the observed increase in the ratio of pre-B to immature B cells 
was due to an abnormal expansion of pre-B cells, and since broader changes in cell numbers in 
the bone marrow of these animals might be missed by the above analyses, B-lineage cell counts 
were collected from each bone marrow subpopulation. The results were consistent with those 
described above: the only difference among the various genotypes was a reduction of immature 
B cell numbers in the E -deficient mice (both the VH
a
WT
b
 and VH
a
JH animals) (Table 3-1). 
We conclude that in the bone marrow of E -deficient mice, there was no extra pre-B cell 
accumulation, but immature B cells did not emerge in normal numbers. 
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Table 3-1: Cell numbers in the bone marrow of mice carrying the B1-8VH knock-in allele 
(with and without E ). 
Bone marrow cells from the indicated genotypes were stained for B cell surface markers B220, 
IgM and IgD (n=number animals analyzed). Cell numbers for the indicated subpopulations were 
calculated from percentages obtained in flow-cytometry, multiplied by the total cells recovered 
(20000 cells collected and analyzed for each animal). Lymphocytes were identified by 
conventional forward and side-scatter gates; live cells among these were further identified by 
Propidium Iodide (PI) stain-exclusion; B-lineage cell subpopulations were identified as described 
both in the text and in Figure legend 3.1. Cell numbers are provided ± SD. n = number of 
animals analyzed. p-values were calculated by two-tailed student’s t-test using GraphPad Prism 5. 
p>0.05: no significant difference. p<0.05: significant difference (italicized and bold in table). 
 
VH
a
/WT
b
 
n=4 
VHE
a
/WT
b
 
n=4 
 
VH
a
/ JH 
n=6 
VHE
a
/ JH
 
n=6 
 
Lymphocytes 3970±293 4020±246 p=0.89988 4690±194 4486±183 p=0.46253 
Live cells 3859±300 3883±249 p=0.95261 4563±190 4355±175 p=0.43753 
B220+ cells 573±51 720±46 p=0.07036 1216±166 1225±48 p=0.60969 
(Pro+Pre-B) cells 341±61 377±41 p=0.61772 983±130 778±28 p=0.15489 
Immature B cells 39±5 115±19 p=0.01406 142±23 234±16 p=0.00859 
Mature B cells 191±21 224±34 p=0.48124 88±14 108±11 p=0.27722 
Ratio of (pro/pre-B) 
to immature B 
8.709±0.795 3.598±0.418 p=0.00025 7.215±0.451 3.395±0.216 p<0.0001 
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3.2. E -deficient (VH
a
) B cells develop normally after the immature B cell stage 
 Absence of E  does not adversely affect cell development after the immature B cell stage 
Immature B cells differentiate to “transitional” B cells, and the first in a phenotypically-
distinguishable series of such cells is the transitional B cells of type 1 (T1 B cell) in the bone 
marrow. The cell surface markers including B220, CD21, CD23, IgM, and IgD were stained and 
analyzed to compare the newly formed T1 (NF T1, B220
+
IgM
+
IgD
low
) B cell compartments in 
the bone marrow of VHE
a
JH and VH
a
JH mice. Among IgM
+
 B cells in the bone marrow, 
the CD21
-
CD23
-
 cells constitute the combined pool of immature and NF T1 B cells. As shown in 
Figure 3.2A and 3.2B, this combined pool in VH
a
JH mice was ½ the size of that in VHE
a
JH 
mice (22.43% versus 42.16%), consistent with the diminished immature B cell compartment in 
these animals. However, the ratios of immature to NF T1 B cells (distinguished by levels of IgM 
and IgD expression; immature, B220
+
IgM
+
IgD
-
; NF T1, B220
+
IgM
+
IgD
low
 (232-235)) were 
indistinguishable in these two mouse strains (3.72±0.18 versus 3.41±0.18; Figure 3.2C, D). This 
demonstrates that although the size of NF T1 B cell compartment was reduced in mice 
expressing the E -deficient allele, the reduction was directly related to the smaller number of 
immature B cell “precursors” from which they arose. There was no evidence that the efficiency 
of NF T1 cell development was itself compromised by the deletion of E .  
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Figure 3.2:  Immature and transitional (T1) B cells are found at similar ratios in 
VHE
a
/ JH and VH
a
/ JH mice.  
A. Representative flow-cytometry plots of bone marrow cells gated for IgM+, and analyzed for 
CD23 and CD21 surface expression. Quadrants for recirculating, mature B cells 
(CD21
+
CD23
+
) and for a mixture of immature B and NF T1 (newly-formed T1) B cells 
(CD21
-
CD23
-
) are indicated. Percentage cells are calculated relative to total IgM
+
 cells.  
B. Bar graphs comparing immature+NF T1 B cell pools in VHE
a
/WT
b
 and VH
a
/WT
b
 mice 
(gated as shown in A). Three (n=3) age-matched animals (2-3 months) of each genotype 
were analyzed. Error bars show SD. p-value calculated by a two-tailed student’s t-test. 
C. Representative flow-cytometry plots of bone marrow cells gated for B220+ and analyzed for 
IgM and IgD expression. Gates are shown for immature B cells (IgM
+
IgD
-
), NF T1 B cells 
(IgM
+
IgD
low
), and recirculating, mature B cells (IgM
+
IgD
high
). Percentage cells are calculated 
relative to total B220
+
 cells. 
D. Ratios of IgD-/IgDlow (immature/NF T1) B cells in the bone marrow of VHE
a
/ JH and 
VH
a
/ JH mice. Subsets gated as in C. Numbers of mice analyzed are indicated (n=); mice 
were 2-3 months of age. Error bars show SD. ns = non-significant (calculated by two-tailed 
student’s t-test). 
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E -deficient B cell development appears to be normal after the immature B stage, even with a 
restricted generation of immature B cells. Consistent with our previous study, normal numbers of 
B cells were found in adult spleen of VH
a
/WT
b
 mice (Table 3-2, Figure 3.3, (146)). The 
proportion of B cells (~50% of total live lymphocytes) in the spleen of VH
a
/WT
b
 mice wasn’t 
different from that of VHE
a
/WT
b
 mice. Study of chimeras reconstituted with normal and B-cell 
deficient bone marrow cells have shown that the continuous pre-B cell input is necessary for 
maintaining a physiologically normal peripheral B cell compartment, but the number of 
peripheral B cells is independent of pre-B cell numbers (236), indicating that the peripheral B 
cell compartment reaches its homeostasis autonomously. Although the turnover of naive B cells 
in the spleen is high because they are short-lived and there is continuous influx of bone marrow 
immature B precursors, recent studies have shown that these naive mature B cells, like naive T 
cells and natural killer cells (237-240), undergo a homeostatic proliferation independent of 
antigen in the spleen to expand this cell pool (241, 242). And then the antigen-dependent 
proliferation in the follicles largely increase the size of mature B cell compartment by producing 
memory and plasma cells, reaching a physiological homeostasis in the spleen (243, 244). 
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Table 3-2: Cell numbers in the spleen of mice carrying the B1-8VH knock-in allele (with 
and without E ). 
Cells from the spleens of different heavy chain modified mice with and without E  were 
recovered and stained for B cell surface markers (B220) and T cell surface marker (CD3 ). Cell 
number for lymphocyte subpopulations were calculated based on total cell count (20000 cells 
collected for each animal) and the percentage of total cells comprising each subpopulation 
determined by flow cytometry. Dead cells were excluded by PI dye staining. p-values were 
calculated by two-tailed student’s t-test. p>0.05: no significant difference; 0.01<p<0.05: 
significant difference; 0.001<p<0.01: very significant difference; p<0.001: extremely significant 
difference. n = number of animals analyzed. 
 
VH
a
/WT
b
 
n=2 
VHE
a
/WT
b
 
n=3 
 
VH
a
/ JH 
n=3 
VHE
a
/ JH 
n=3 
 
Lymphocytes 3850 ± 10 4547 ± 293 p=0.16292 4427 ± 29 4547 ± 293 p=0.70457 
Live cells 3725 ± 8 4257 ± 325 p=0.29356 4054 ± 115 4257 ± 325 p=0.58586 
B220+ B cells 1674 ± 121 1926 ± 411 p=0.47886 1691 ± 334 1926 ± 411 p=0.48663 
CD3+ T cells 1636 ± 52 1870 ± 187 p=0.19789 1543 ± 266 1870 ± 187 p=0.15670 
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Figure 3.3: Normal percentage of B cells in the spleen of VH
a
/WT
b
 mice. 
Splenic lymphocytes form different heavy chain modified mice with and without E  were 
recovered and stained for B cell surface markers (B220) and T cell surface marker (CD3 ). 
Percentages of lymphocyte subpopulations are calculated relative to the total live lymphocytes. 
Shown is a representative histogram of 3 individual experiments. 
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For this reason, it was not surprising to find normal B cell numbers in spleens of VH
a
/WT
b
 mice, 
despite the immature B cell deficiency evident in the bone marrow. On the other hand, B cells in 
the spleens of neonatal mice are essentially immature B cells, whereas mature B cells are absent 
throughout the 1
st
 week of life (245). During this neonatal period (1
st
 week of life), the newborn 
actively develop their immune system to reach a hematopoietic homeostasis with mature B and T 
lymphocytes, under the cooperation of the infant spleen, bone marrow and liver (246, 247). 
Neonatal splenic B cell counts were collected in VHE
a
/WT
b
 and VH
a
/WT
b
 mice. As shown in 
Figure 3.4, in the VH
a
/WT
b
 mice, new-born splenic B cells (analyzed on the day of birth) were 
half the number found in VHE
a
WT
b
 newborns. The early wave of immigrants to spleen, 
therefore, is reduced in size in the E -deficient mice. We suggest that as the splenic B cells 
eventually mature, the mature B cell compartment reaches its normal size over time by 
homeostatic and antigen-induced proliferation (241), and then remains at this normal level once 
built up, masking the aberrant immature B cell subsets. 
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Figure 3.4: Neonatal spleens of VH
a
/WT
b
 mice have fewer B cells.  
Splenic B cell counts of the indicated genotypes. Newborn mice were analyzed at birth (day 1). 
n=number of spleens analyzed. Bar graph shows numbers of B220
+
 cells per 10
5
 total splenic 
cells. Error bars indicate Standard Deviation (SD); p-value determined by two-tailed t-test 
(GraphPad Prism 5).  
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We also analyzed B cell subsets in the spleens of adult VHE
a
/WT
b
 and VH
a
/WT
b
 mice. As 
shown in Figure 3.5, steady-state B cell numbers were the same for both T1 (IgM
+
CD21
-
CD23
-
) 
and T2+mature (IgM
+
CD21
+
CD23
+
) B cell compartments in the two strains. In our previous 
studies, we found that in the VH
a
/WT
b
 mice, IgH-double-producers were enriched in the 
marginal zone B cells of the spleen (146). Consistent with those earlier findings, we again 
noticed that the marginal zone B cell population (IgM
+
CD21
+
CD23
low
) was at a higher frequency 
inVH
a
/WT
b
 mice than in VHE
a
/WT
b
 mice (4.719% versus 2.390%, percentages relative to total 
IgM
+
 splenic lymphocytes) (Figure 3.5). 
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Figure 3.5: B cell subsets in the spleen of VH knock-in mice with and without E . 
A. Flow cytometry profiles of IgM+ splenic B lymphocytes, and analyzed for CD21 and CD23 
expression. T1 B cells (CD21
-
CD23
-
), T2+mature B cells (CD21
+
CD23
+
), marginal zone B 
cells (CD21
+
CD23
low
). Gates and percentage cells in gates are indicated (% calculated 
relative to total B220
+
 cells). Data shown are representative of at least 3 age-matched animals 
(3-4 months) of each genotype.  
B. Percentages of T1 B, T2+mature B, and MZ B cells in the spleen of indicated genotypes 
(calculated relative to IgM
+
 cells). n= number of animals analyzed. p-value determined by 
two-tailed student t-test. Error bars show SD.  
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In conclusion, when E  is missing, bone marrow B-cell development is partially impaired at the 
pre-B to immature B cell transition, so that the immature B cell compartment does not 
accumulate to a normal size. B cell populations at other stages including the earlier pre-B and the 
later transitional and mature B cell stages, however, are not affected directly by E -deletion. 
3.3. E -deficient B1-8VH heavy chain (VH
a
) is expressed at a lower level in pre-B cells 
As a cis-control transcriptional enhancer, one of E ’s important functions is to enhance Ig heavy 
chain expression after VH gene assembly. For this reason, it is worthwhile to examine the Ig  
expression level in pre-B cells from E -deficient mice. To do so, VHE
a
WT
b
 and VH
a
WT
b
 
mice were bred onto the RAG1
-/-
 background. In the absence of Rag1 protein, B cell 
development in RAG1
-/-
 mice with wild type Ig loci (WT
b
/WT
b
 RAG1
-/-
) is arrested at the pro-B 
cell stage, which can be identified by surface CD43 (leukosialin) expression in combination with 
the cell size analysis by FACS (89). In VHE
a
WT
b
 RAG1
-/-
 and VH
a
WT
b
 RAG1
-/-
 mice, 
however, the B1-8VH knock-in heavy chain gene restores the arrested RAG1
-/-
 pro-B cells to the 
small pre-B cell stage. B220
+
 BM cells from these VH knock-in, RAG1
-/-
 mice are smaller in size 
(Figure 3.6A) and express lower levels of CD43 than the comparable B220
+
 BM cells from the 
WT
b
/WT
b
 RAG1
-/-
 mice (Figure 3.6B), supporting the idea that BM B cells of these VH knock-in 
mice (VHE
a
WT
b
 RAG1
-/-
and VH
a
WT
b
 RAG1
-/-
) have progressed to but are stalled at the pre-
B cell stage. Bone marrow cells from VH
a
/WT
b
 RAG1
-/-
 and VHE
a
/WT
b
 RAG1
-/-
 mice were 
isolated and assayed by flow cytometry to measure cytoplasmic Ig protein levels. As previously 
reported, the progression from pro-B, through large pre-B, to small pre-B was not adversely 
affected by E  deletion (Figure 3.6A, B and (146)), but Ig  expression was reduced in the pre-B 
cells of VH
a
/WT
b
 RAG1
-/-
 mice to ½ the levels seen in pre-B cells of VHE
a
/WT
b
 RAG1
-/-
 mice 
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(Figure 3.6C, D and (146)). B-lineage cells in the bone marrow of the VHE
a
/WT
b
 RAG1
-/-
 and 
VH
a
/WT
b
 RAG1
-/-
 mice, therefore, differ only with respect to the levels of cytoplasmic Ig  
available for pre-BCR assembly. 
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Figure 3.6: Reduced cytoplasmic Ig  expression in pre-B cells of VH
a
/WT
b
 RAG1
-/-
 mice. 
A. Forward scatter plot showing sizes of WT pro-B cells versus B1-8VH knock-in pre-B cells. 
B220
+
 lymphocytes from bone marrow of RAG1-deficient VHE
a
/WT
b
, VH
a
/WT
b
 and 
WT
b
/WT
b
 mice were analyzed. Genotypes as indicated in B.    
B. Flow cytometry plot of CD43 expression of WT pro-B cells (WTb/WTb RAG1-/-) versus B1-
8VH knock-in pre-B cells (VHE
a
/WT
b
 RAG1
-/-
 and VH
a
/WT
b
 RAG1
-/-
).  
C. Representative histogram of B220+ bone marrow cells stained for intracellular Ig  and 
analyzed by flow cytometry (genotypes indicated in legend). Isotype control: cells treated 
with an irrelevant antibody of the same isotype as that of the monoclonal antibody to mouse 
Ig . 
D. Bar graphs quantifying mean fluorescence of cytoplasmic Ig  in pre-B cells analyzed as 
shown in A. Error bars show SD; p-values calculated by GraphPad Prism 5. 
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3.4. Small pre-B cells of E -deficient (VH
a
) mice have reduced B cell receptor signaling 
Light chain gene assembly after Ig  expression, with the consequent formation of a signaling-
competent B cell receptor, is essential for the transition from the pre-B to immature B cell stage. 
Having confirmed that this transition was compromised in VH
a
WT
b
 and VH
a
JH mice, we 
asked whether the defect could be explained by a decrease in the signaling strength of newly-
emerging BCRs. In pre-B cells, pre-BCR signals dominate over newly-emerging BCRs because 
light chain gene assembly is ongoing and most pre-B cells lack a functionally assembled IgL 
gene. While our interest was in the signals of newly-emerging B1-8 H-chain BCRs, we reasoned 
that any change in their signal due to the observed reduction of Ig  in VH
a
/WT
b
 pre-B cells 
would similarly affect B1-8 H-chain pre-BCR signals in these cells. We therefore focused on B1-
8 H-chain pre-BCR signals in VH
a
WT
b
 and VHE
a
WT
b
 mice since their receptor structures 
were identical, which is B1-8 Ig  + SLC in both. However, the amount of Ig  available for pre-
BCR assembly differed significantly. To directly compare pre-BCR signals in the small, non-
proliferating pre-B cell population poised for Ig light chain gene assembly and expression, we 
tested the VHE
a
WT
b
 and VH
a
WT
b
 mice on the RAG1
-/-
 background, where there is no light-
chain gene assembly, thereby restricting signals to those mediated by the pre-BCR.  
Membrane expression of Ig  in the form of a pre-BCR or BCR, induces intracellular signals as a 
series of tyrosine phosphorylation (ligand-independent or antigen-induced), which controls B 
cell differentiation and selection. The pre-BCR and BCR initiated signaling process depends 
critically on the ITAM region on the cytosolic tail of the Ig molecules (154, 158, 160, 164, 
167, 248). After phosphorylation of tyrosine residues on the ITAMs, the protein tyrosine kinase 
(PTK) Syk (spleen tyrosine kinase) is recruited to the phospho-ITAMs and activated, which turns 
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on various signaling pathways for further signal transduction (175, 249). Syk is known to be a 
protein kinase involved in mediating multiple signaling events, such as phospholipase C 2 
(PLC 2) activation and calcium mobilization (149, 250-252). Deletion of Syk led to 
developmental block at the pro-B to pre-B cell transition, which is a hallmark of defective pre-
BCR signaling (253-255). Syk-deficient cells with a transgenic BCR failed to maintain the 
mature B cell pool, suggesting the critical role of Syk in BCR signaling (252). Extracellular 
signal-regulated kinase (Erk) is a protein kinase downstream of protein tyrosine kinase Syk (256). 
It is a key participant in pre-BCR and BCR mediated tonic signaling pathway which regulates 
the activities of a series of transcription factors and thereby their target genes (170, 178). B 
lymphocytes in mice deficient in both Erk1 and Erk2 were defective in pre-BCR-dependent 
transcriptional events, showing impaired cell expansion and a block at the pro-B to pre-B 
transition (170). Since Syk and Erk are essential for both pre-BCR and BCR signaling, it is 
conceivable that the cytoplasmic phosphorylation of total tyrosine, Syk and Erk depends on and 
is directly proportional to B cell receptor signal strength. 
Bone marrow B cells from VHE
a
/WT
b
 RAG1
-/-
 and VH
a
/WT
b
 RAG1
-/-
 mice were treated with 
sodium pervanadate, a protein-tyrosine phosphatase (PTP) inhibitor, in order to analyze tonic 
signals mediated by the pre-BCR (158, 165). The effect of sodium pervanadate in signaling 
studies is to block the activity of intracellular PTPs which counterbalance signals generated by 
the receptors, so that the weak or transient signals can be stabilized and revealed (158, 231, 257, 
258). The pervanadate-treated cells were then permeabilized and incubated with antibodies 
specific for phosphorylated Erk (pErk), for phosphorylated Syk (pSyk), and for phospho-tyrosine 
residues, in general (pTyr). As shown in Figure 3.7A, mean levels of these phosphorylated 
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proteins (pSyk, pErk, and of global tyrosine-phosphorylated proteins) were lower, in every case, 
in VH
a
/WT
b
 RAG1
-/-
 pre-B cells. 
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Figure 3.7: Pre-BCR signals are attenuated in the small pre-B cells of VH
a
/WT
b
 RAG1
-/-
 
mice.   
A. Histograms of pre-B cells stained with antibodies to the phosphorylated (activated) forms of 
the indicated proteins. B220
+
 cells from bone marrow of VHE
a
/WT
b
 RAG1
-/-
 and VH
a
/WT
b
 
RAG1
-/-
 mice were treated with the phosphatase inhibitor pervanadate and then fixed and 
permeablized before incubation with antibodies. pErk = phosphorylated form of 
“extracellular signal-regulated kinase”; pSyk = phosphorylated form of “spleen tyrosine 
kinase”; pTyr = phosphorylated tyrosine residues on any/all cell proteins. Controls are pre-B 
cells stained with isotype-matched antibodies (no specificity for mouse proteins). Histograms 
shown are representative of 3 independent experiments with 2 month-old mice of the 
indicated genotypes.  
B. Histograms of immature B cells stained with antibodies to the phosphorylated (activated) 
forms of the indicated proteins as discussed in A. B220
low
sIgM
+
 bone marrow cells from 
bone marrow of VH
a
/ JH and VHE
a
/ JH mice were analyzed. Histograms shown are 
representative of 3 independent experiments with 2.5 month-old mice of the indicated 
genotypes.  
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3.5. E -deficient B1-8VH heavy chain (VH
a
) is expressed at the normal level in immature 
and mature B cells 
We and others have suggested that once cells reach the immature B cell stage, E  is no longer 
required for normal levels of Ig  mRNA and protein. This is because the 3’ regulatory region 
(3’RR, Figure 1.2) becomes active and can efficiently enhance Ig  expression at this stage (213, 
214, 259). To test this hypothesis, we compared Ig  protein levels in pre-B, immature and 
mature B cells of VHE
a
/ JH and VH
a
/ JH mice. In these mice, B cell development and BCR 
expression is entirely dependent upon the VHE
a
 and VH
a
 alleles, respectively. Bone marrow 
cells were stained for surface B220 and IgM (sIgM). Cells were then fixed, permeablized and 
incubated with antibodies to cytoplasmic Ig . Immature B cells were identified as B220
low
sIgM
+
. 
As shown in Figure 3.8A, surface IgM levels varied over a broad range in these immature B cells 
from these mice, but the overall profiles overlapped when E  was and was not present on the 
knock-in allele (VHE
a
/ JH and VH
a
/ JH cells, respectively). Similarly, as has been reported 
before for VHE
a
WT
b
 and VH
a
WT
b
 mice (146), splenic B cells from VHE
a
/ JH and VH
a
/ JH 
mice expressed identical levels of surface IgM (Figure 3.8B). Cytoplasmic Ig  in the immature 
bone marrow cells were of no difference between these two genotypes (Figure 3.8D, F). This 
contrasts with what was seen in pre-B cells (B220
+
sIgM
-
, no surface IgM) from the same animals. 
As in the pre-B cells from VH
a
/WT
b
 RAG1
-/-
 mice (Figure 3.6C, D), cytoplasmic Ig  levels 
were reduced in pre-B cells from VH
a
/ JH to almost ½ that in pre-B cells from VHE
a
/ JHmice 
(Figure 3.8C, F). Reduced cytoplasmic Ig  in pre-B cells and normal cytoplasmic Ig  levels in 
immature/mature BM B cells were also evident when the entire population of B220
+
 bone 
marrow cells were similarly analyzed (Figure 3.8E). Note that the peaks corresponding to cells 
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with high levels of cytoplasmic Ig  (immature/mature B cells) were juxtaposed for B220
+
 of 
both genotypes, but the peaks for cells with comparatively low cytoplasmic Ig  (pre-B cells) 
were displaced from one another, with the peak forVH
a
/ JH pre-B cells lying left (lower 
cytoplasmic Ig ) of that forVHE
a
/ JH pre-B cells. In summary, the E -deficient allele produced 
significantly less Ig  protein in pre-B cells than did the same gene with E  present, but this 
deficiency no longer existed in immature/mature BM B cells, nor in splenic B cells.   
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Figure 3.8: Ig  is not reduced in immature B cells expressing an E -deficient allele. 
A. Representative histogram of surface IgM-staining on immature B cells of VHE
a/ΔJH and 
VH
a/ΔJH mice. Immature B cells identified and gated as B220
low
sIgM
+
. Isotype control = 
cells incubated with an irrelevant fluorescent antibody with the same isotype as the 
monoclonal antibody to mouse Ig . Representative of 4 independent experiments. 
B. Representative histogram of surface IgM-staining on splenic B cells of VHE
a/ΔJH and 
VH
a/ΔJH mice. B220
+
 splenic cells were analyzed for surface IgM expression. 
Representative of 4 independent experiments. 
C. Representative histogram of cytoplasmic Ig -staining in pre-B cells from VHE
a/ΔJH and 
VH
a/ΔJH mice. Bone marrow cells gated for B220
+
sIgM
-
 (pre-B cells). Shown is 
Representative of 4 independent experiments. 
D. Representative histogram of cytoplasmic Ig -staining in immature B cells of VHE
a/ΔJH and 
VH
a/ΔJH mice. Bone marrow cells gated for B220
low
sIgM
+
 (immature B cells). 
Representative of 4 independent experiments. 
E. Representative histogram of cytoplasmic Ig -staining in bone marrow B220+ cells from 
VHE
a/ΔJH and VH
a/ΔJH mice. Peaks on the left correspond to cytoplasmic Ig  in pre-B 
cells; peaks on right correspond to cytoplasmic Ig  in immature and mature B cells. 
Representative of 4 independent experiments. 
F. Bar graph quantifying cytoplasmic Ig  in pre-B and in immature B cells from bone marrow 
of VHE
a/ΔJH and VH
a/ΔJH mice. Mice of each genotype (3 months old) were analyzed in 
four individual experiments. Error bars show SD. p-value calculated by two-tailed student’s 
t-test. ns = non-significant. 
110  
 
111  
3.6. Immature B cells of E -deficient (VH
a
) mice have normal B cell receptor signaling 
The BCR signals in immature B cells represent only those that have successfully passed the tests 
of both positive and negative selections, with sufficient and appropriate signaling properties. We 
asked whether the return to equivalent levels of intracellular Ig and of surface IgM would lead 
to equivalent tonic signaling. B220
low
sIgM
+
 immature B cells from the VHE
a
/ JH and VH
a
/ JH 
mice were analyzed for signaling in the same manner as described for pre-B cells. As shown in 
Figure 3.7B, flow-cytometry plots of the phosphorylated, active forms of the relevant kinases 
and overall phosphorylated tyrosine levels were indistinguishable for the immature B cells from 
these two mouse strains. This was in striking contrast to the signals from pre-B cells in the VH 
knock-in mouse strains with and without E (Figure 3.7A). The difference in signaling detected 
within the pre-B cells was not found within the immature B cells, consistent with the reduced Ig  
levels in pre-B cells but same IgM expression in immature B cells with and without E . 
3.7. Onset of -light chain gene transcription and rearrangement is normal in pre-B cells 
expressing the Eµ-deficient heavy chain (VH
a
) 
There could be a smaller immature B cell compartment if light-chain gene rearrangement is not 
activated normally in Ig -expressing pre-B cells. Since the onset of light chain gene 
rearrangement is dependent upon pre-BCR signaling (161), and we have found that B1-8 H-
chain pre-BCR signals were reduced in pre-B cells of VH
a
/WT
b
 RAG1
-/-
 mice (Figure 3.7A), 
we asked whether the reduced signals had resulted in a defect in the activation of light-chain 
gene assembly, thereby leading to less efficient population of the immature B cell pool. To 
answer this, we examined two hallmarks of Ig  locus activation: Ig  germ line gene transcription 
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(94) and recombination-activating gene 2 (RAG2) expression. Pre-B cells from VH
a
/WT
b
 
RAG1
-/-
 and VHE
a
/WT
b
 RAG1
-/-
 mice were isolated, and germline transcripts from the kappa 
light chain (Ig ) locus and RAG2 mRNA quantified by reverse transcriptase-dependent, 
quantitative (real-time) polymerase chain reaction (PCR). As shown in Figure 3.9A, Ig  germ 
line transcripts and RAG2 transcripts (both essential for subsequent V -to-J  recombination) 
were found at comparable levels in the pre-B cells of VHE
a
/WT
b
 RAG1
-/-
 and VH
a
/WT
b
 
RAG1
-/-
 mice. That the Ig  germ line transcripts were dependent upon pre-BCR signals was 
supported by the fact that B220
+
 bone marrow cells from RAG1
-/- 
mice without the VH knock-in 
(and therefore unable to make a pre-BCR; WT
b
/WT
b
 RAG1
-/-
 in Figure 3.9A, left panel) were 
devoid of these transcripts. The same cells from WT
b
/WT
b
 RAG1
-/-
 mice were positive for 
RAG2 transcripts (Figure 3.9A, right panel), since these are pro-B cells poised to undergo D-to-
JH and VH-to-DJH recombination but unable to do so because of the absence of RAG1. These 
results suggested that the onset of light-chain gene rearrangement was not disturbed in 
VH
a
/WT
b
 pre-B cells, despite the lower B1-8 H-chain pre-BCR signals in these cells. 
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Figure 3.9: RAG2 and germline kappa light chain (Ig ) gene transcription is normal in 
pre-B cells of mice expressing the E -deficient allele. 
A. Bar graphs comparing RAG2 and germline Ig transcript levels in B220+ lymphocytes from 
bone marrow of RAG1-deficient VH
a
/WT
b
, VHE
a
/WT
b
 and WT
b
/WT
b
 mice. Germline Ig  
transcripts (left panel) and RAG2 mRNA (right panel) levels were determined by quantitative 
RT-PCR. Ig  and RAG2 mRNA of VH
a
/WT
b
 RAG1
-/-
 pre-B cells are set as 1.0. Pro-B cells 
of WT
b
/WT
b
, RAG1
-/-
 littermates served as a negative control for Ig  germline transcripts 
(absence of pre-BCR precludes onset of Ig  transcription) and as a positive control for RAG2 
expression (absence of IgH gene assembly sustains expression of the RAG1 and RAG2 
genes). mRNAs from WT
b
/WT
b
, RAG1
-/-
 splenic cells (no B cells) were included as negative 
controls for both analyses. All analyses were normalized to hgprt1 mRNA to exclude 
variations of input RNA templates. Five age-matched animals (2 months) of each genotype 
were analyzed.  Statistical significance (ns: not significant) was determined by two-tailed 
student’s t-test. 
B. Representative flow-cytometry plots of B220+sIgM- bone marrow lymphocytes (pre-B cells), 
stained for cytoplasmic Ig  (upper panels) or for cytoplasmic Ig  (lower panels). % positive 
cells are indicated in the lower right quadrant of each plot. Data are representative of 
analyses of three age-matched mice (2 months) of each genotype. 
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In mice that are not deficient for RAG1, Ig  germline transcription and RAG1/RAG2 expression 
are followed by V gene assembly and subsequent Ig  protein expression. We compared percent 
pre-B cells expressing cytoplasmic Ig  in the pre-B cells of VHE
a
/ JH and VH
a
/ JH mice. The 
percentages of pre-B cells expressing Ig were similar in these two mouse strains (18.97% 
versus 18.53%, Figure 3.9B upper panels). In short, germline Ig  transcription, RAG2 
transcription, and cytoplasmic Ig  protein expression in pre-B cells were unaffected by the 
deletion of E , again suggesting a normal onset of Ig  rearrangement in the pre-B cells of 
VH
a
/ JH mice. We conclude that pre-BCR signaling, while reduced in pre-B cells expressing an 
E -deficient IgH gene, remains sufficient to induce normal levels of light chain gene assembly. 
The smaller immature B cell compartment in these animals, therefore, results from a deficiency 
operating after this process.   
3.8. -deficient (VH
a
) B cells have undergone increased light chain editing 
V  assembly and Ig  protein expression can occur following Ig  usage and is generally regarded 
as evidence of light chain editing (to rescue cells that have not been able to assemble a functional 
Ig  gene or that express an Ig  BCR with autoreactive properties). We compared percent pre-
B cells expressing cytoplasmic Ig  in the pre-B cells of VHE
a
/ JH and VH
a
/ JH mice. There 
was a detectable subpopulation of pre-B cells expressing cytoplasmic Ig  only in the VH
a
/ JH 
mice (4.395%, Figure 3.9B lower panels). This finding is consistent with our previous study 
showing increased light-chain editing in splenic B cells from these mice (146). As discussed in 
more detail later, we believe this light-chain editing resulted not from expression of autoreactive 
BCRs but from the inability of many newly-formed BCRs to reach the signaling threshold for the 
pre-B to immature B cell transition.  
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In addition, in VH
a
/WT
b
 heterozygous mice, “single-producers” express their BCRs entirely 
dependent upon Ig  from an E -deficient allele. These single-producers from the immature and 
splenic B cell compartments included more lambda chain producers than their “double-producer” 
counterparts. As shown in Figure 3.10, in the bone marrow (upper panel) and spleen (lower panel) 
of VH
a
/WT
b
 mice, surface IgM
a
+ cells (left panels) include a subpopulation that express the 
lambda light chain. But when cells express IgM
b
 as double-producers (which must also co-
express IgM
a
 from the pre-assembled VH gene, right panels), they do not express Ig , suggesting 
that there is no excessive light chain editing in these IgH-double-producers. This is consistent 
with the evidence of splenic B cells having undergone unusually high levels of light-chain 
editing in VH
a
/ JH mice (B cells in these mice are all IgH-single-producers) (146).  
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Figure 3.10: Increased light chain editing in E -deficient VH
a
/WT
b
 B cells. 
Cell surface staining of Ig  and IgM
a
/IgM
b
 on bone marrow and splenic B cells in 
VH
a
/WT
b
mice. B220
+
 live lymphocytes gated and shown. Most cells expressing both heavy 
chain alleles are not expressing  chains, whereas Eµ-single producers are more likely to 
express the  light chain.  
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3.9. A pre-assembled light chain gene (3-83V ) partially rescues allelic exclusion and pre-
B to immature B cell transition in mice expressing the VH
a
 heavy chain 
As described previously and shown in this study, mice heterozygous for a functional, but E -
deficient IgH allele (VH
a
/WT
b
 mice) exhibited a profound defect in allelic exclusion, with 
approximately 20% splenic B cells expressing both the mutant heavy chain and an assembled 
WT
b
heavy chain (“double-producers”, (146)). Immature and splenic B cells whose BCRs are 
entirely dependent upon Ig  from an E -deficient allele (as in VH
a
/ JH mice or “single-
producers” in VH
a
/WT
b
 mice) showed evidence of having undergone unusually high levels of 
light-chain editing (Figure 3.10 and (146)). We have suggested that both phenotypes are due to a 
decrease in Ig  which results in diminished B1-8VH-BCR signals often insufficient to reach the 
threshold for positive selection. To circumvent this problem, cells that have only the E -deficient 
allele available for expression (as “single-producers”) continue to edit their light chain until they 
generate a BCR with superior signaling ability, overcoming the defects of low receptor density. 
Double-producers, on the other hand, assemble and express the second IgH
b
 allele (that retains 
E ), thereby reversing their deficiency in Ig levels, giving these cells a selective advantage.  
To further test the hypothesis that light chain editing in single-producers is functionally related to 
the transition of pre-B cells to the immature B cell stage, and to the outgrowth of double-
producers in VH
a
WT
b
 mice, we asked whether limiting cells to a single light chain sequence 
would not only affect the pre-B to immature B cell transition of single-producers but also the 
relative advantage afforded to double-producers in the same animals. VH
a
WT
b
 mice were bred 
to a strain that carries a functional 3-83V  knock-in gene (a pre-assembled kappa light chain 
variable region gene) on the Ig  locus. B cell subpopulations were compared in the resulting 
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VH
a
WT
b
 3-83 /Ig mice versus the VH
a
WT
b
 mice. As shown in Figure 3.11 and Figure 3.12, 
the relative size of the immature B cell pool was greatly increased in the presence of the 3-83V  
knock-in gene (Figure 3.11A left panel, Figure 3.11C and Figure 3.12). Importantly, this increase 
was accompanied by fewer double-producers in both the immature and splenic B cell 
compartments (Figure 3.11A middle and right panels and Figure 3.11B). Ig -producing cells 
also reduced in number by the 3-83V  knock-in light chain (from 11.3% to 4.7% splenic B cells, 
Figure 3.13). We interpret these results as evidence that the B1-8VH/3-83V  combination results 
in a BCR with stronger signaling properties than the average BCR in normal wild-type cells 
expressing a wide repertoire of light chain genes. This IgH/IgL combination largely compensates 
for the lower than normal levels of Ig because of E -deletion. The result is a more rapid 
progression of single-producers from the pre-B to the immature B cell stage (after little or no 
light chain editing), and also a reduction in the selective advantage of double-producers over 
single-producers in these animals. 
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Figure 3.11: 3-83V knock-in gene reduces the incidence of double-producers in VH
a
/WT
b
 
mice. 
A. Left panels: Flow cytometry profiles of bone marrow cells gated for lymphocytes, and 
analyzed for B220 and IgM expression. B220
low
IgM
+
 = immature B cells (% immature B 
cells indicated). Middle panels: Flow cytometry profiles of bone marrow immature B cells as 
gated on the left, analyzed for IgM
a
 and IgM
b
 expression (% double producers within 
immature B cell population indicated). Right panels: Flow cytometry profile of B220
+
 
splenic cells (B cells), analyzed for IgM
a
 and IgM
b
 expression. (% double producers within 
splenic B cells indicated). Data shown are representative of at least 4 age-matched animals 
(3-4 months) of each genotype.  
B. Data of double-producers as analyzed in A. n= number of animals analyzed. p-value 
determined by two-tailed student t-test. Error bars show SD. 
C. Ratios of pro/pre-B to immature B cells in the bone marrows of indicated genotypes 
(calculated as in Figure 3.1). n= number of animals analyzed. p-value determined by two-
tailed student t-test. Error bars show SD.  
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Figure 3.12: 3-83V knock-in gene increases the efficiency of pre-B to immature B cell 
transition in E -deficient mice. 
A. Flow cytometry profiles of B220+ bone marrow lymphocytes, and analyzed for IgM and IgD 
expression. Immature B cells (IgD
-
IgM
+
), pro-B+pre-B cells (IgD
-
IgM
-
). Gates and 
percentage cells in gates are indicated (% calculated relative to total B220
+
 cells). Data 
shown are representative of at least 3 age-matched animals (3-4 months) of each genotype.  
B. Ratios of pro-B+pre-B to immature B cells in the bone marrows of indicated genotypes 
(calculated as in Figure 3.1). n= number of animals analyzed. p-value determined by two-
tailed student t-test. Error bars show SD.  
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Figure 3.13: Decrease in Ig -producers in mice expressing both the E -deficient IgH allele 
and a 3-83V  knock-in Ig  allele. 
Flow cytometry profiles of B220
+
 splenic lymphocytes (B cells) analyzed for Ig  and Ig  
expression. % Ig  and Ig  expressing cells calculated relative to total B220
+
 cells. Genotypes 
indicated above the plots.  Plots shown are representative of 3 independent experiments. 
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3.10. In VH
a
/WT
b
 mice, allelically “included” B cells (expressing two different IgHs) bear 
a higher probability of auto-reactivity 
A relationship between the expression of two different BCRs and autoreactivity has long been 
conjectured as an evolutionary explanation for the development of “allelic exclusion” in B 
lymphocytes. Having developed a mouse strain with a profound defect in allelic exclusion, we 
asked whether the double-producers from these animals were at increased risk of expressing 
autoreactive receptors. 
In a preliminary screen by ANA (anti-nuclear antibody) test for autoimmune antibodies, 8/13 
(61%) sera from the VH
a
/WT
b
 animals showed moderate to high levels of reactivity to the 
nuclei, while 3/20 (15%) sera from the VHE
a
/WT
b
 animals showed the comparable reactivity 
(data not shown). To extend these analyses, we examined sera from mice of these and additional 
genotypes for anti-dsDNA reactivity by enzyme-linked immunosorbant assay (ELISA). Included 
in these analyses were two mouse strains that carried the VH
a
 allele but were unable to generate 
double-producers, either because they were homozygous for the VH
a
 allele (VH
a
/VH
a
 or 
because they lacked a functional second heavy chain allele (VH
a
/ JH). To directly compare IgM 
expressed from the B1-8VH knock-in allele, which is present in all genotypes with and without 
E , we used an anti-IgM
a
 antibody to detect the anti-dsDNA antibodies in these mouse sera. As 
shown in Figure 3.14A, the IgM
a
 in sera from VH
a
/WT
b
 animals contained significantly higher 
anti-dsDNA reactivity than did IgM
a
 from any of the other genotypes (VHE
a
/WT
b
, VH
a
/VH
a
 
VH
a
/ JH or VHE
a
/ JH).  
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To test more directly for anti-dsDNA BCRs among B cell double-producers in the spleen, we 
isolated and cultured B220
+
 spleen cells from VH
a
/WT
b
 mice (contain ~20% double-producers) 
and VHE
a
/WT
b
 mice (no double-producers) with LPS for 7 days. As shown in Figure 3.14B left 
panel, these two cultures produced comparable amounts of IgM
a
, rising well above the 
background by Day 3. However, culture supernatants from the VH
a
/WT
b
 culture showed a 
striking rise in IgM
a
 antibodies reactive to dsDNA over time, while this did not occur in the 
VHE
a
/WT
b
 cell cultures (Figure 3.14B right panel).  
To prove whether this IgM
a
 anti-DNA antibody (expressed from the VH
a
 IgH gene) was being 
produced by the single-producers and/or by the double-producers in the VH
a
/WT
b
 animals, we 
sorted VH
a
/WT
b
 splenic B cells into these two subpopulations (IgM
a+b-
 single-producers, and 
IgM
a+b+
 double-producers) and cultured them separately with LPS. Culture supernatants were 
analyzed on day 7, for their anti-dsDNA antibody levels. As shown in Figure 3.14C left panel, 
again IgM
a
 secretion overall was the same in both cultures. However, only the double-producers 
secreted IgM
a
 anti-dsDNA antibody (Figure 3.14C right panel). We concluded therefore, that 
anti-dsDNA BCRs are more prevalent on the double-producers of VH
a
/WT
b
 mice than on 
single-producers in the same mice or in VHE
a
/WT
b
 mice. Their anti-dsDNA reactivity is 
associated with IgM
a
 protein expressed from the VH
a
 knock-in IgH. As discussed below, we 
interpret this as evidence that the BCRs formed with Ig
a
 from the E -deficient allele are not 
only of insufficient density to signal positive selection but also are unable to signal negative 
selection. 
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Figure 3.14: Anti-dsDNA reactivity from B1-8VH allele of B cells expressing two different 
receptors in VH
a
/WT
b
 mice. 
A. IgMa (B1-8VH) anti-dsDNA proteins in sera from mice of the indicated genotypes. Y-axis = 
(OD405 of IgM
a
 anti-dsDNA)/(OD405 of total IgM
a
) in sera. This ratio of the standard IgM
a
 
anti-dsDNA monoclonal antibody is set at 1.0 and not shown in figure. Means and standard 
deviations are shown as horizontal lines with vertical brackets Dots correspond to sera from 
individual animals analyzed at 5-6 months of age. PBS was used as a negative control. 
B. IgMa (B1-8VH) anti-dsDNA in supernatants of LPS-stimulated cultures, and harvested at the 
indicated times. Both total IgM
a
 proteins (left panel) and IgM
a
 anti-dsDNA antibodies (right 
panel) in splenic B cell cultures were compared, from VH
a
/WT
b
, VHE
a
/WT
b
 and WT
b
/WT
b
 
mice. PBS was used as negative a control. Data shown is representative of 3 individual 
experiments. 
C. IgMa anti-dsDNA antibody secretion by double-producers. VH
a
 single-producers (SP, 
IgM
a+b-
) and VH
a
/WT
b
 double-producers (DP, IgM
a+b+
) from spleens of VH
a
/WT
b
 mice 
were sorted, cultured in LPS and culture supernatants harvested at day 7. Total IgM
a
 proteins 
produced by SP and DP (left panel); IgM
a
 anti-dsDNA antibodies produced by SP and DP 
(right panel). PBS was used as anegative control. Bar graph is a statistical analysis of 3 
individual experiments. p-values were calculated by two-tailed student’s t-test. ns= non-
significant. 
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As we have previously shown, VHE
a
/WT
b
 and VH
a
/WT
b
 mice differ profoundly with respect 
to allelic exclusion (146). The double-producers among the immature and splenic B cell subsets, 
characteristic of VH
a
/WT
b
 mice, are absent in VHE
a
/WT
b
 mice. However, there are double-
producers in VHE
a
/WT
b
 mice, which are restricted to the peritoneal cavity of these mice (146). 
As a consequence of these cells, IgM
b
 is present in the sera of VHE
a
/WT
b
 mice at about the 
same level as in VH
a
/WT
b
 mice. We used this as a means for asking whether the absence of E  
(resulting in lower Ig  and hence BCR density) was responsible for the increased frequency of 
anti-dsDNA antibodies, or alternatively, any BCR on double-producers (even when both BCRs 
are encoded by E -intact alleles) would have a greater likelihood of autoreactivity. We found no 
difference in serum IgM
b
 anti-dsDNA level in VHE
a
/WT
b
 versus VH
a
/WT
b
 versus C57BL/6J 
(WT
b
/WT
b
) mice (Figure 3.15A), although the IgM
b
-BCR showed some background levels of 
anti-dsDNA reactivity both in sera (Figure 3.15A). Splenic B cells from VHE
a
/WT
b
, VH
a
/WT
b
 
and C57BL/6J mice were cultured in vitro and analyzed for secretion of anti-dsDNA proteins 
with IgM
b
 allotype. There is very low level (close to background PBS control) of IgM
b
 in the 
culture supernatant from VHE
a
/WT
b
 splenic B cells since few, if any, detectable splenic B cells 
making IgM
b
 in these mice. Double-producers from VH
a
/WT
b
 mice secrete IgMb proteins, 
which showed reactivity to dsDNA (Figure 3.15C). Not only VH
a
/WT
b
, but also C57BL/6J 
splenic B cells secreted IgM
b
 and these proteins showed anti-dsDNA reactivity as well, 
consistent with the IgM
b
-anti-dsDNA detected in sera. There is reasonable concordance between 
the levels of IgM
b
-anti-dsDNA levels and IgM
b
 protein levels in the cell cultures of VH
a
/WT
b
 
and C57BL/6J splenic B cells: the more IgM
b
 expressed, the higher anti-dsDNA activity detected 
(Figure 3.15B). This demonstrates that IgM
b
 secreted by VH
a
/WT
b
 B cells are not more likely to 
be autoreactive. We suggest, accordingly, there is no alteration in the selection of BCRs 
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containing Ig  from the WT
b
 allele that retains E . Only BCRs comprised of Ig
a
 from the E -
deficient allele showed evidence of defective negative selection in double-producers.  
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Figure 3.15: Anti-dsDNA reactivity from WT
b
 allele of B cells expressing two different 
receptors in VH
a
/WT
b
 mice. 
A. IgMb (WTb) anti-dsDNA proteins in sera from mice of the indicated genotypes. Y-axis = 
(OD405 of IgM
b
 anti-dsDNA)/(OD405 of total IgM
b
) in sera. Means and standard deviations 
are shown as horizontal lines with vertical brackets. Dots correspond to sera from individual 
animals analyzed at 5-6 months of age. PBS was used as a negative control. 
B. IgMb (WTb) anti-dsDNA in supernatants of LPS-stimulated cultures, and harvested at the 
indicated times. Both total IgM
b
 proteins (left panel) and IgM
b
 anti-dsDNA antibodies (right 
panel) in splenic B cell cultures were compared, from VH
a
/WT
b
, VHE
a
/WT
b
 and WT
b
/WT
b
 
mice. PBS was used as a negative control. Data shown is representative of 3 individual 
experiments. 
C. IgMb anti-dsDNA antibody secretion by double-producers. VH
a
 single-producers (SP, 
IgM
a+b-
) and VH
a
/WT
b
 double-producers (DP, IgM
a+b+
) from spleens of VH
a
/WT
b
 mice 
were sorted, cultured in LPS and culture supernatants harvested at day 7. Total IgM
b
 proteins 
produced by SP and DP (left panel); IgM
b
 anti-dsDNA antibodies produced by SP and DP 
(right panel). PBS was used as a negative control. Bar graph is a statistical analysis of 3 
individual experiments. p-values were calculated by two-tailed student’s t-test. ns= non-
significant. 
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Chapter 4: Discussion 
4.1. B cell development and B cell receptor signaling of E -deficient mice 
4.1.1. Deletion of E  results in an impaired pre-B to immature B cell transition, leaving 
other developmental stages unaffected 
4.1.2. Deletion of E  reduces Ig  expression, resulting in suboptimal receptor signaling in 
pre-B cells but not in immature B cells 
In both mice and humans, pre-B to immature B cell transition in the bone marrow is an important 
checkpoint at which an emerging BCR is tested for its functionality and autoreactivity (162, 260, 
261). Cells expressing anti-self receptors are arrested at this transition and subsequently clonally 
deleted (180, 262-265). Signals propagated by these auto-reactive receptors can also reactivate 
the recombination machinery (RAG genes) to induce receptor editing of IgH or IgL chain genes 
in pre-B cells. As a result, non-self-reactive receptors replace the original autoreactive specificity 
and rescue the B cell differentiation into the immature B cell stage (226, 266-269). On the other 
hand, cells expressing non-autoreactive receptors continue to differentiate by signals sent out 
from the pre-BCR and BCR in a ligand-independent and/or ligand-dependent manner (158, 162). 
In the present study, we provide evidence that nascent BCR signals must reach a signaling 
threshold for the positive selection of the pre-B cells into the immature B cell stage and that the 
BCR’s ability to reach this threshold is a function of both receptor structure (IgH/IgL 
combination) and abundance. Insufficient nascent BCR signals result in sustained light chain 
rearrangements in pre-B cells for a better IgH/IgL combination. The role of the Igh intronic 
enhancer, E  at this transition, is to ensure sufficient expression of the IgH gene (and hence 
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enough abundance of BCR), so that most IgH/IgL combinations form BCRs reaching the 
signaling threshold for positive selection.  
In the absence of E , Ig  was expressed at half of the normal level in pre-B cells, which was 
correlated with discernibly lower levels of tyrosine phosphorylation for the total cytoplasmic 
proteins, as well as for the pre-BCR and BCR signaling molecules Syk and Erk. We interpret this 
as evidence for a decrease in pre-BCR and BCR receptor signaling strength in these pre-B cells. 
We conclude therefore, the low Ig  levels translate into low pre-BCR and BCR levels that in 
turn lead to tonic signals of reduced average signal strength. Correlated with the lower Ig  and 
lower receptor signals, we found the immature B cell compartment to be less efficiently 
populated in these E -deficient mice, such that at the steady state, it was half the size of that in 
the genetically matched mouse strain with E  intact and with twice the amount of Ig  in pre-B 
cells. In our E -deficient model, the decreased Ig  in pre-B cells, therefore, compromises the 
positive signal sent by a newly-formed BCR which is required for the transition from the pre-B 
to immature B cell stage. As a result, pre-B cells expressing both the E -deficient and the wild-
type Igh alleles are at a selective advantage because their tonic signals through the emerging 
BCRs could reach the threshold for survival.  
This is consistent with a previous study which showed that BCR signals are critical to 
maintaining immature B cells at the immature B cell stage (222). Ablation of tonic BCR signals 
in immature B cells through inducible gene deletion of surface Ig or chemical inhibition of 
tyrosine kinases, resulted in back-differentiation of the immature B cells into the pre-B cell stage 
and recommencement of light chain editing (222). The current study provides further and more 
direct evidence that BCR signaling plays a dominant role for B cell differentiation, especially at 
135  
the pre-B to immature B cell transition. We further demonstrate that there is a signaling threshold 
for pre-B cells to differentiate into immature B cells. Reduced BCR signals, not solely loss of all 
BCR signals as caused by BCR ablation, leads to defective transitioning. 
While others have described the effects of perturbing Ig  levels and/or BCR signals in 
genetically-modificed mice (e.g. (178, 222, 270-273), a unique feature of the current 
experimental system is that Ig expression is not irreversibly depressed throughout B cell 
development in VH
a
 mice. Instead, Ig  expression returns to wild-type levels in E -deficient 
immature B cells and in their descendants ((146) and Figure 3.8). As we and others have shown, 
the transcription of IgH and hence Ig  levels, are controlled by not only the Igh intronic 
enhancer E  but also a downstream regulatory region at the 3’ end of the Igh locus (3’RR) (215, 
274, 275). As shown here, Ig  levels in pre-B cells depend in large part upon the transcriptional 
enhancer E  whereas earlier studies have shown that the 3’RR sustains high-level IgH gene 
transcription in Ig-secreting cells, even in the absence of Eµ (206-210). Reciprocal loss of the 
3’RR in Ig-secreting cells led to a dramatic decrease in Ig transcription (206, 211, 212). These 
findings suggested that Eµ’s role in promoting IgH transcription could be supplanted by the 3’ 
IgH enhancers at the plasma-cell stage. Later studies have shown that the 3’RR becomes active 
as early as the immature B cell stages (213-215). Taking all these observations together, we 
suggest accordingly that 3’RR up-regulates Ig  expression at immature and mature B cell stages 
to the normal level, and Ig  expression becomes independent of E  when cells reach the 
immature B cell stage. As we show in immature B cells, this return to wild-type Ig  level 
correlated with a return to normal levels of BCR-signals (as measured by phosphorylation of 
tyrosine residues, active forms of Syk and Erk) and resumption of normal B cell development 
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past this stage (Figure 3.2, 3.3, 3.7, 3.8). The levels of phosphorylated signaling molecules in 
pre-B and immature B cells are in agreement with the relative Ig  levels in these cell populations, 
confirming our hypothesis that as a critical constituent of pre-BCR and BCR, Ig  levels 
correspond to the receptor levels and therefore the tonic signaling strengths of BCRs in 
developing B cells.  
More recently, a hypomorphic HC model caused by reporter gene (GFP: green fluorescence 
protein) insertion into the intron between E  and JH gene segments, showed also reduced Ig  
expression but from all IgH genes formed (by VHDJH recombination) on the affected allele. This 
effect (variable) on Ig  transcription was at all B cell developmental stages. In this model, BM 
B-cell development was partially impaired at all stages and affected cells had increased receptor 
editing; and the distribution of B cell subsets was skewed (B-1a, B-1b, marginal zone, and B-2 B 
cells). In addition, with lower Ig  level, there was reduced level of BAFF receptors on splenic B 
cells and impaired antibody responses, suggesting decreased BCR signaling (271). This study is 
supportive to our notion that reduced Ig  expression results in reduced pre-BCR and BCR levels 
and suboptimal signals, which perturb the pre-B to immature B cell transition and trigger 
ongoing light chain editing (see section 4.2).  
4.2. Receptor editing in E -deficient B cells 
4.2.1. Cells expressing only the VH
a
 allele undergo extensive receptor editing 
4.2.2. A pre-assembled 3-83V  light chain gene rescues the pre-B to immature B cell 
transition during VH
a
 B cell development 
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4.2.3. A pre-assembled 3-83V  light chain gene partially reduces the incidence of IgH 
double-producers in VH
a
/WT
b
 mice 
Importantly, the current study shows that the significance of the enhancer E is not limited to its 
roles in IgH gene assembly and transcription. It serves another important function in ensuring the 
development of a broad B cell receptor repertoire among emerging B cells. This means absence 
of E  affects not only emerging B cell numbers (size of immature B cell compartment, as 
discussed above), but also the emerging B cell repertoire (discussed below).  
In cells expressing low levels of Ig , formation of a functional IgL gene is often insufficient to 
signal differentiation to the immature B cell stage because of the low BCR levels and signaling. 
In such cells, even when they have successfully expressed BCRs, light chain gene 
rearrangements do not cease (as demonstrated by the hallmarks of light chain “editing”), because 
these cells cannot efficiently “sense” the presence of BCRs through the under-expressed signals. 
There would be insufficient RAG down-regulation, resulting in ongoing light chain 
recombination or developmental arrest. We postulate that this increased light chain editing also 
reflects a more stringent requirement for the BCR potency due to the reduced  levels at the pre-
B cell stage, which drives the cell to create an IgH/IgL combination with better signaling 
properties. Evidences for this are 1) reduced immature B cell compartment in E -deficient mice; 
and 2) increased light-chain editing suggested by Ig  gene structures (more usage of the most 
downstream J  gene segment) and by Ig  gene expression (more Ig -producing cells) in 
immature B cells expressing an E -deficient IgH gene. The expected outcome would be a 
reduction in the BCR repertoire because of the more stringent requirements for Ig light chain 
structure. In the presence of E  and of higher lg  proteins, however, more IgH and IgL 
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combinations meet the necessary threshold more frequently, allowing for an expanded (and 
likely more protective) repertoire of B cell receptors. 
We show further evidence that IgL sequence and structure affect B cell development in E -
deficient mice with low Ig at the pre-B cell stage. Provided with a pre-assembled 3-83V  
knock-in IgL gene, VH
a
/WT
b
 mice had an increased size of immature B cell compartment, so 
that the ratio of (pro-B+pre-B)/immature B cells reduced from an average of 7 to <1. We suggest 
therefore, the B1-8VH and 3-83V  pair exemplifies an IgH and IgL combination which signals 
better than others, so that even when Ig  level is low, the basal level of signaling by this receptor 
is sufficient to support the pre-B to immature B cell transition. We selected to use the 3-83V  
knock-in gene because it had already been shown that B1-8H-chain and 3-83  light chain form a 
functional BCR that can support B cell development (226). But we didn’t know whether this 
combination was able to circumvent the defect caused by low Ig  levels due to E -deficiency. 
Had this BCR (B1-8H/3-83 ) been of lower-than-threshold signaling properties, we might have 
found a more pronounced decrease of immature B cell compartment. This was not what we 
found, however. A relative decrease in size of the (pro-B+pre-B) cell compartment and increase 
in size of the immature B cell compartment are commonly found in IgH/IgL knock-in mice as 
long as the BCR is not autoreactive (e.g. (226)). What was remarkable in the B1-8VH and 3-
83V  double knock-in mice, however, was the effect on heavy chain allelic exclusion: double-
producers significantly reduced in numbers among both immature and splenic B cell 
compartments in VH
a
/WT
b
 3-83 /Ig  mice, as compared to VH
a
/WT
b
 Ig /Ig  mice.  
As described earlier, one of the striking phenotypes in mice heterozygous for the E -deficient 
allele (VH
a
/WT
b
), is the defect in allelic exclusion (146). Approximately 20% splenic B cells 
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expressed Ig  from both the VH
a
 knock-in and the wild-type IgH chains (“double-producers”). 
A fundamental requirement for the clonal selection theory of B lymphocytes is that each B cell 
expresses an antigen receptor of a single specificity, so that individual B cell clones are 
effectively and efficiently selected for their functionality and against their auto-reactivity during 
development, and also quickly produce antibodies upon exposure to their cognate antigen (17). 
The core mechanism responsible for allelic exclusion involves feedback inhibition of VH to DJH 
joining on the second allele after successful VHDJH recombination has taken place on the first 
allele. We have previously shown that this process occurs normally, in both VH
a
/WT
b
 and 
VHE
a
WT
b
 mice. Both the VH
a
 and VHE
a
 alleles strongly inhibit VH to DJH assembly on the 
WT
b
 allele, but neither fully blocks the generation of pre-B cells with a second functional VH 
gene on the WT
b
 allele. These rare precursors to double-producers are present in the pre-B cell 
populations of both VH
a
/WT
b
 and VHE
a
WT
b
 mice (146). When E  remains on the VH knock-
in allele, however, immature and mature B cells never emerge from these rare precursors, 
revealing a second, E -dependent, “check-point” for IgH allelic exclusion at the pre-B to 
immature B cell transition. We suggest that this, in fact, is another manifestation of the inability 
of the VH
a
 allele to produce Ig , and therefore BCR, at levels sufficient for positive selection. 
“Double-producers” in VH
a
/WT
b
 mice are not eliminated at this check-point because the 
functionally assembled IgH gene on the second allele, which retains E , allows for BCR levels 
sufficient for positive selection. We assume that this puts double-producers at a selective 
advantage over single-producers (no E ) at the pre-B to immature B cell transition in VH
a
/WT
b
 
mice due to the lower Ig  expression from only the VH
a
 allele. 
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Consistent with this hypothesis, the current study shows that genetic manipulations that augment 
the pre-B to immature B cell transition in single producers from VH
a
/WT
b
 mice (using the pre-
assembled 3-83V  gene), simultaneously augment allelic exclusion (i.e. reduce the outgrowth of 
cells with BCRs of two different specificities as double-producers). Double-producers are at a 
selective advantage at the pre-B to immature B cell transition in VH
a
/WT
b
 mice only because of 
the signaling defect caused by low Ig  levels in single-producers. In the VH
a
/WT
b
 3-83 /Ig  
mice, this signaling defect is greatly reversed because of a potent BCR comprised of B1-8VH and 
3-83V . All these observations support our hypothesis that BCR signal is a determining factor 
for cells to traverse the pre-B to immature B cell stage, and in the selection “check-point” for 
allelic exclusion. 
4.3. Pre-BCR dependent B cell progression is normal in E -deficient B cells 
While these lower Ig  levels strongly affect the phenotype of emerging B cells, which includes a 
more limited repertoire and the persistence of double-producers, our data suggest that they have 
no clear effect on the outcomes of pre-BCR signaling in our E -deficient, B1-8VH knock-in 
model. We have found that the processes preceding the pre-B to immature B cell transition are 
much less dependent upon Ig  levels than is the development and selection of immature B cells.  
As we have shown previously, the 1
st
 “check-point” in allelic exclusion (i.e. the feedback 
inhibition of VH-to-DJH rearrangement on the 2
nd
 Igh locus), while mediated by membrane 
Ig and the signaling molecules Ig  and Ig (67, 124, 132, 272, 273, 276), is fully operational in 
B1-8VH knock-in animals and is unaffected by E  deletion (146). 
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The pre-BCR (composed of Ig , SLC, Ig  and Ig ) induces differentiation of the pro-B to the 
pre-B cell stage, proliferative expansion of large pre-B cells, differentiation of large pre-B to 
small pre-B cells, and subsequent down-regulation of SLC expression as well as onset of Ig light 
chain gene rearrangements in non-dividing small pre-B cells (132, 161, 272, 273, 277-279). In 
our E -deficient, B1-8VH knock-in model, none of these pre-BCR-associated processes was 
adversely affected. Pro-B and pre-B cell differentiation appeared normal in the absence of E . In 
both VH
a
/WT
b
 and VHE
a
/WT
b
 mice, all cells carry a productively rearranged B1-8VH heavy 
chain, and as a result, they largely bypass the pro-B cell stage and progress directly to the small 
pre-B stage for light chain assembly. There is no obstruction at the pro-B to pre-B cell transition, 
and instead, pro-B cell compartments were of no discernible differencce in size in the two strains 
(both reduced relative to wild-type, Figure 3.6A, 3.6B), suggesting an equivalent response to pre-
BCR signals. We found equivalent numbers of pre-B cells in the VH
a
/WT
b
 versus VHE
a
/WT
b
 
mice, as well, suggesting that the pre-BCR-mediated proliferative expansion and differentiation 
were also taking place normally in the absence of E .  
A caveat to this interpretation is that deficient pre-B cell expansion might be masked by these 
cells’ inefficient, BCR-mediated exit into the immature B cell compartment. Otherwise, pre-B 
cell numbers might have been expected to rise because of this inefficient exit. Alternatively, pre-
BCR-mediated proliferation may be normal, and instead, apoptosis of BCR-signal-deficient cells 
balances the slow exit.  
In any case, in small, non-dividing pre-B cells, re-expression of RAG-1 and RAG-2 genes and 
Ig locus germ line transcription (as a prelude to Ig  gene assembly) (161, 279), both being 
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processes mediated by pre-BCR signals, occurred at equivalent levels whether E was present or 
absent on the expressed Ig  allele (Figure 3.9). 
Taken together, all of these findings support the conclusion that the signaling threshold for pre-
BCR-mediated processes is lower that that of BCR-mediated ones. As a result, pre-BCR signaled 
events are not affected by the absence of E  as long as a functional VH gene (such as B1-8VH) 
has already been assembled. The pre-BCR density and therefore signal strength reaches the 
signaling “threshold” in VH
a
 mice, so that the development of precursor B cells until small pre-
B stage is not affected. Rather, after VH gene assembly, E ’s importance is next manifested only 
at the pre-B to immature B cell transition where BCR (not pre-BCR) signaling is required and 
tested. 
4.4. Comparison with previous studies: strengths of the VH
a
 model 
As mentioned earlier, this study extends and refines the earlier studies by BCR ablation, 
providing evidence of a signaling threshold at the pre-B to immature B cell transition. While loss 
of BCR and/or BCR signaling results in defective cell differentiation, a reduction of pre-
BCR/BCR signaling strength would also cause deficiencies.    
Others have shown that truncation of the Ig  cytoplasmic tail causes significant decrease of pre-
B and immature B cell numbers, supporting the importance of receptor signaling (280). Notably, 
however, the inhibition of immature B cells generation was greater than was the effect on pre-B 
cell generation, suggesting that higher signaling capacities are required as B cells progress 
through development (149). This is in agreement with our finding that pTyr, pSyk and pErk 
levels increase progressively from the pro-B to pre-B, and then to the immature B cell stage (data 
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not shown). Taken together, we suggest that pre-BCR signals are not as “density” dependent as 
are the BCR signals.  
Previous models for study on receptor signaling involved either ablations of BCR genes that led 
to cell death or involved mutants that affected BCR levels or signaling throughout B cell 
development, not allowing for a focus on BCRs’ roles at a specific transition point. For example, 
in the hypomorphic HC model, the transcriptional depression was sustained throughout 
development. Ig  expression was reduced to 1/10 of the wild-type level, which resulted in 
developmental deficiencies at all stages during B cell maturation. Therefore, it was difficult to 
assign a mutant phenotype conclusively to perturbation of any one particular selection process 
(i.e. it was difficult to assign a specific role for Ig  level at specific points of transition). In 
comparison, our E -deficient VH knock-in model provides us with a system where Ig  
expression is less severely impaired (to only half the wild-type level), and this impairment occurs 
only in pre-B cells. Consequently, the reduction of BCR levels is limited to the pre-B to 
immature B cell transition, allowing for a focus on BCR signaling at this particular and 
functionally important juncture, when B cell receptors are tested for their signaling competence 
and autoreactivity. This experimental system also allows us to identify the specific stage at 
which E ’s functions (and its effects on Ig  expression) are critical. 
Moreover, another advantage of this experimental system is that we can directly attribute effects 
to Ig  mRNA and protein levels, without the confounding effects of differences in nucleic 
acid/amino acid sequence, since all comparisons among cell stages in VH
a
 mice and between 
VHE
a
 and VH
a
 mice are of cells expressing the same recombined IgH gene with identical VH 
and IgH promoter. The only difference is the presence or the absence of the intronic enhancer, 
144  
and therefore emerging B cells differ only in the Ig (mRNA and protein) level at the pre-B to 
immature B cell transition. This relatively small reduction in Ig  expression at this transition 
yields large effects on the B cell and antibody repertoire, both reducing the breadth and allowing 
for development of B cells with two different receptors. 
4.5. E -deficient VH
a
/WT
b
 heterozygous mice are prone to B cell autoimmunity 
Finally, as we pointed out in the results, allelic exclusion has long been conjectured to have 
evolved as a means for ensuring the clonal selection of each B cell, either positively (selected for 
expansion, when receptor binds an invading pathogen) or negatively (selected for elimination, 
when receptor binds a host product) depending on the specificity of the BCR it displays (18). 
The separate selection of individual B cells is an efficient means for assuring that protective 
receptors are maintained and autoreactive receptors are eliminated (18). If B cells carry more 
than one receptor, then antigen-induced expansion of such allelic included cells would result in 
simultaneous production of the protective and autoreactive antibodies. In support of this notion, 
several studies have identified the presence of allelic included expression of either IgH or IgL in 
mouse and human B cells carrying autoreactive specificity (137, 138, 145, 281-287). These 
studies with Ig transgenic or Ig ‘knock-in” mice have demonstrated that, co-expression of self-
reactive and non–self-reactive receptors enables developing B cells to escape negative selection 
and differentiate into mature lymphocytes.Interpretations include: 1) the receptor with high 
avidity to self-antigen is concealed in the cytoplasm and is not detectable on the cell surface, so 
that the B cell co-expresses a second receptor with an innocuous specificity for maturation. Only 
when the innocuous BCR is stimulated is the second, autoreactive antibody revealed through 
secretion from the resulting plasma cell (Ig-secreting) cell (137, 145); 2) allelic- or isotype-
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included co-expression of two light chains (express two Ig  alleles, or Ig  and Ig  chains) 
results in competition for assembly with the available IgH chain, diluting the surface density of 
both BCRs and therefore making neither sufficiently “visible” for negative selection (137, 138, 
282, 284). However, the mechanisms for the survival of these B cells with dual-receptors have 
not yet been thoroughly elucidated.  
While allelic “inclusion” constitutes a risk-factor for autoimmunity, several studies have shown 
that “double-producers” are not, a priori, autoreactive (141, 288). Studies by Makdasi and Eilat 
(2013) provided evidence that allelic-included B cells in diseased autoimmune mice (systemic 
lupus erythematosus, SLE) were generally not autoreactive. Reciprocally, B cells with DNA-
specific BCRs were no more likely to be allelically included (double-producers) than were non-
autoreactive B cells (288). The authors suggested that light chain allelic exclusion is merely a 
byproduct of receptor editing, but not a mechanism for autoreactive receptors to be ignored for 
negative selection. Otherwise, allelically included B cells should retain both autoreactive and 
non-autoreactive receptors (288). This conclusion is reminiscent of another previous study, 
which showed that allelic inclusion does not necessarily result in autoreactive B cells (141). We 
suggest that allelic inclusion should not be viewed as an absolute marker for autoimmunity: 
while some double-producers will produce both autoreactive and innocuous BCRs, others will 
emerge with two innocuous (protective) ones. Allelic inclusion, therefore, constitutes a risk-
factor for autoimmunity, not a singular cause for it.   
In the current study, the double-producers in high numbers in VH
a
/WT
b
 mice (but not in 
VHE
a
/WT
b
 mice) provide an example of how “allelic-included” cells can contribute to the risk 
for autoimmunity. We find that these “double-producers” (VH
a
+WT
b
) include a subpopulation 
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with autoreactive BCRs expressed from the E -deficient (VH
a
) allele. We suggest that the 
difference in the expression level of Ig  from two different IgH alleles explains the cells’ ability 
to transit from pre-B to immature B cells, unchecked for the specificity of the light chain plus -
heavy chain from the VH
a
 allele. As we have shown in mice dependent solely upon expression 
of the VH
a
 allele, this E -deficient allele drives expression of a BCR often insufficient for 
positive selection. We suggest that actually this makes it also impervious to negative selection at 
the pre-B to immature B cell transition. When a 2
nd
 IgH allele with E  is expressed, the resultant 
double-producer will be selected on the basis of this 2
nd
 “wild-type” heavy chain, for both 
positive and negative selection. Given that a newly formed B cell receptor (IgH/IgL combination) 
is autoreactive at a frequency as high as 75% (260, 289), these double-producers will sometimes 
prove autoreactive because of the inability to sense and test the autoreactive properties of BCRs 
formed by B1-8 H-chain (from the VH
a
allele, at half of the wild-type leve) plus light chain at 
the pre-B to immature B cell transition. For this reason, protective and auto-reactive receptors 
will arise on single cells in emerging immature B cells (Figure 4.1). As the “double-producers” 
mature and differentiate into plasma cells, the tested IgM
b
 molecules and the untested IgM
a
 
molecules are both secreted. Consistent with that hypothesis, we found that only in the 
VH
a
/WT
b
 mice (not in VHE
a
/WT
b
 mice expressing the same B1-8 H chain), and only in 
double-producers from VH
a
/WT
b
 mice, were there anti-dsDNA antibodies associated with the 
B1-8 H chain (Ig
a
; Figure 3.14). 
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Figure 4.1: Model for auto-reactive VH
a
/WT
b
 double-producers.  
In VH
a
/WT
b
 mice, newly emerging immature B cells may express both the knock-in and the 
wild-type (WT) Igh alleles in order to pass positive selection at the pre-B to immature B cell 
transition. These cells express the E -deficient allele (VH
a
) at half the level of the WT-Igh 
(WT
b
). The VH
a
-BCR is “invisible” for both positive and negative selection due to its lower 
density. Instead, cells are positively and negatively selected only by the WT
b
-BCR. Therefore, 
the resultant Ig-secreting cells will produce both non-autoreactive antibodies (from the WT
b
-
BCR) and autoreactive antibodies (from the VH
a
-BCR) once activated. 
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In general, although allelic-inclusion does not always involve an auto-reactive receptor, we 
predict that when it does, cells with one self-reactive receptor will escape clonal deletion, 
allowing cells to differentiate into autoantibody secreting plasma cells and pose a threat of 
autoimmunity. It should be noted, however, in our E -deficient VH-knock-in mice, except for the 
increased IgM anti-dsDNA and anti-nuclear antigen reactivity in sera, we have found no 
evidence of autoimmune disease in these animals up to 6 months of age. Assays for sera IgG
a
-
anti-dsDNA antibodies were negative, suggesting that the cells secreting IgM
a
-anti-dsDNA 
antibodies were not commonly undergoing class-switching (in germinal centers) and forming 
IgG-secreting plasmacytes. No proteinuria was detected and blood urea nitrogen levels in these 
mice were indistinguishable from age-matched wild-type animals (data not shown), suggesting 
that there was no development of glomerulonephritis or autoimmune disease in our model.  
Nevertheless, the difference in the development of IgM
a
-anti-dsDNA antibodies in the matched 
mouse strains (VH
a
/WT
b
 versus VHE
a
/WT
b
) and in double- versus single-producers clearly 
shows that BCR selection is profoundly affected by the presence of a second BCR with 
alternative specificity. Presumably, if within an autoimmune mouse background, the double-
producers (expressing one E -deficient VH-knock-in allele) would increase the likelihood of 
autoimmune disorders. 
4.6. It is the E -deficient VH knock-in allele (VH
a
), not the WT
b
 allele, that predispose 
VH
a
/WT
b
 heterozygous mice to B cell autoimmunity 
As noted above, it has been suggested that double-producers might give rise to auto-antibodies 
because neither of two alternative BCRs is present at high enough levels to make it subject to 
negative selection. In our model, however, one BCR (IgM
a
) is presumably present at half the 
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level of the other (IgM
b
). We focused on IgM
a
 anti-dsDNA antibodies since our question was 
whether the antigen-specificity of the B1-8 H chain BCRs was assessed differently in single-
producers (where this BCR drives positive selection and thus, would be expected to be subject to 
negative selection, as well) versus double-producers (where we predict that this BCR is neither 
driving positive selection nor is subject to negative selection). We have shown that the IgM
a
 
BCR is behaving differently (with respect to selection) when expressed on single-producers 
versus double-producers.  
It might be asked whether there is a reciprocal effect on the IgM
b
 BCR even though it is 
expressed at twice the levels of the IgM
a
 BCR at the critical pre-B to immature B cell transition. 
Serum IgM
b
 from the VH
a
/WT
b
 and VHE
a
/WT
b
 animals proved informative in this regard. We 
were able to look at IgM
b
 anti-dsDNA antibodies in sera of both VHE
a
/WT
b
 and VH
a
/WT
b
 
mice, since VHE
a
/WT
b
 mice produce IgM
b
 at similar levels as VH
a
/WT
b
 mice, presumably 
deriving from the double-producers found among peritoneal B cells of VHE
a
/WT
b
 mice (which 
were not found in the immature B and splenic B cell compartments in these mice) (146). Anti-
dsDNA antibodies are a hallmark of lupus erythematosus in humans, but such antibodies, 
particularly IgM anti-dsDNA, are also found in healthy people. Similarly, we found detectable 
amounts of IgM
b
 anti-dsDNA antibodies in C57BL/6J mice. It should be noted that there was 
anti-dsDNA reactivity associated with these IgM
b
 proteins in sera from both VHEµ
a
/WT
b
 and 
VH
a
/WT
b
 mice and at the same frequency (and both had levels equivalent to normal age 
matched C57BL/6J mice), suggesting that a subset of BCRs with anti-dsDNA IgM
b
 encoded by 
the WT
b
 IgH locus was retained in the repertoire as a result of antibody diversification, probably 
due to their mild anti-dsDNA affinity allowing the cells to survive negative selection. 
150  
IgM
b
 BCRs in both VHE
a
/WT
b
 and VH
a
/WT
b
 mice represent a broad range of VH and VL 
combinations, and the Ig
b
 chain is produced from an allele that retains E , so we would expect 
these BCRs to be subject to both positive and negative selection whether expressed in single or 
double-producers entering the pre-B to immature B cell transition. Consistent with that 
expectation, there was no difference in serum IgM
b
 anti-dsDNA level in VHE
a
/WT
b
 (IgM
b
 from 
double-producers) versus VH
a
/WT
b
 (IgM
b
 from double-producers) versus C57BL/6J (IgM
b
 
produced from single-producers) mice. 
4.7. Summary 
In summary, our observations, together with those previously published, provide compelling 
evidence to support a model in which the constitutive signaling strength of newly emerging BCR 
must reach a threshold in order to promote the pre-B to immature B cell transition. The IgH 
intronic enhancer E ’s important function is to amplify IgH transcription at the pre-B cell stage, 
such that in combination with most IgH promoters, signaling through a functional BCR reaches 
this threshold.  
Loss of E  from a productive IgH allele has profound effects on B cell development and Ig 
repertoire. This results in under-expressed receptor density in pre-B cells, attenuates the receptor 
signaling strength in these cells and yields notable effects on the emerging immature B cells. It 
impairs cell differentiation efficiency, reduces the breadth of receptor repertoire, and may also 
lead to a selection process allowing survival of B cells with two different receptors which 
increases the frequency of autoreactive cells. E ’s important function in allelic exclusion is to 
insure enough levels of Ig  expression to preclude the need for expression of a second allele, and 
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to insure that both BCRs made by the rare double-producer precursors are subject to negative 
selection. This study, in essence, supports the assumption underlying the “clonal selection” 
theory, that B cells express single-specificity receptors to prevent simultaneous activation of 
protective and autoreactive antibody responses. 
A broader implication is that any elements compromising IgH levels (Ig and therefore pre-BCR 
and BCR signals) at this critical transition from pre-B to immature B cell stage during B cell 
development, such as certain weak VH promoters, genetic polymorphisms in enhancer sequence 
and strength, polymorphisms in transcription factors required for enhancer or promoter function, 
will affect the efficiency of cell selection at this important transition stage. A population of B 
cells with multiple receptors will arise because the “weak-signaling” IgH allele functions in 
neither positive nor negative selection, providing a higher potential for autoreactivity. 
Concurrently, such “weak” alleles because of insufficient Ig  will force the use of a restricted 
repertoire of light chains in emerging single-producers because of the need to overcome the 
impaired signaling properties and rescue positive selection, compromising the development of a 
robust and protective antibody repertoire. All these suggest a mechanism by which individuals 
may be predisposed to more restricted versus broader Ig repertoires and/or to autoimmunity. 
 
152  
Chapter 5: Future Directions 
Using the B1-8VH knock-in model, we are able to further describe the defects of B cell 
development and the antibody repertoire caused by expression of an E -deficient IgH gene, 
which deepens our understanding of the nature and mechanism of B cell development regulation. 
There remain some questions that are worthy of further study. 
5.1. Are the B cell development defects (impaired pre-B to immature B cell transition, 
breach in allelic exclusion, and light chain editing toward a more restricted receptor 
repertoire, etc) in VH
a
/WT
b
 mice a direct result of low Ig  levels? 
As proved in the previous and current studies, E ’s role is to increase Ig  levels in pre-B cells 
and thereby to ensure that the signals from newly-formed BCRs are sufficient for the pre-B to 
immature B cell transition and allelic excluded expression of Ig heavy chains. A future 
experiment worthy of consideration is to more directly test the hypothesis that reduced Ig  is the 
sole cause for the impairment in pre-B to immature B cell transition and allelic exclusion. If 
confirmed, the underlying hypothesis is that E  is not alone in affecting the antibody repertoire 
of emerging B cells, since numerous factors (such as VH promoter strength, polymorphisms in 
enhancer sequence and strength, transcription factors for enhancer or promoter activity) also 
contribute to the expression level of newly assembled IgH gene.  
RNA interference technology could be used to knock down Ig  mRNA expression from the 
VHE
a
 allele, to an extent equal to that of the VH
a
 allele. The prediction is that the knock-down 
of Ig  through RNAi to ½ the WT level in VHE
a
 B cells will result in a diminished immature B 
cell repertoire, emergence of double-producers in the immature and splenic B cell populations, 
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and higher light chain editing in single-producers. To accomplish this goal, the conditional RNAi 
technology described by Miething’s lab could be used (290). Mice carrying the inducible shRNA 
(short hairpin RNA, specific for Ig  from the VHE
a
 allele) could be mated to carry the VHE
a
 
allele for this experiment. 
Alternatively, if factors (e.g. the sequence of E , interaction of E  with other cis- or trans-acting 
factors, etc) other than the reduced Ig  level were the causes for the development defects in 
VH
a
/WT
b
 mice (impaired pre-B to immature B cell transition, breach in allelic exclusion, and 
light chain editing toward a more restricted receptor repertoire, etc), then knock-down of Ig  
through RNAi should not result in these defects (or not to the same extent).   
5.2. Can the B cell development defects (impaired pre-B to immature B cell transition, 
breach in allelic exclusion, and light chain editing toward a more restricted receptor 
repertoire, etc) in VH
a
/WT
b
 mice be amplified by decreased BCR signals, or rescued 
by augmented BCR signals? 
We inferred that the reduced Ig  level led to a lower BCR density, which compromised the cells’ 
ability to produce sufficient receptor signals for positive selection of pre-B cells into immature B 
cell stage. It is informative if we test B cell development in VH
a
/WT
b
 mice by controlling the 
levels of BCR signals through manipulations of the downstream signaling pathway. The 
hypothesis is that the defect in allelic exclusion, increase in light chain editing, as well as the 
diminished immature B cell compartment could be reversed by augmented BCR signals, or 
amplified by decreased BCR signals.  
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VH
a
/WT
b
 mice could be mated to mice which carry mutations that increase (Lyn
-/-
) or decrease 
(Btk
-/-
) the BCR signals. Lyn is one of the Src-family tyrosine kinases. Its inhibitory activity has 
been proved by an increase in BCR signaling in immature B cells in the bone marrow of Lyn
-/-
 
mice (Jackson Laboratories B6.129S4-Lyn
tm1Sor
/J, stock#002515) (291, 292). In the double-
mutant VH
a
/WT
b
 Lyn
-/-
 mice, BCR signals at the pre-B to immature B cell transition should be 
increased by relief from the inhibition mediated by Lyn protein. Deletion of the gene for 
Bruton’s tyrosine kinase (Btk-/-, Jackson Laboratories B6.CBA-Btk<xid>/AllmJ, stock#009361)) 
reduces BCR signals. Double-mutant VH
a
/WT
b
 Btk
-/-
 mice should have decreased BCR signals, 
leading to more double-producers and further increases in light-chain editing. VHE
a
/WT
b
 Btk
-/-
 
mice would be expected to generate double-producers in ithe immature and splenic B cell 
population. 
5.3. What are the attributes of light chains that can support the pre-B to immature B cell 
transition when Ig  levels are low? 
It has been shown that VH
a
-single-producers in VH
a
/WT
b
 mice undergo higher light chain 
editing than their (VH
a
+WT
b
)-double-producer counterpart or cells from VHE
a
/WT
b
 mice. 
Provided with a pre-assembled light chain gene 3-83V , VH
a
-single-producers pass positive 
selection at the pre-B to immature B cell transition more efficiently. Our prediction is that some 
IgH/IgL combinations elevate signals to direct pre-B cells into the immature B cell pool through 
either their more stable structure or because of their specificity. In other words, some IgH/IgL 
combinations have better than average signaling properties because they are more efficient to 
assemble with each other, or are more stable on the cell surface.  
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Other IgH/IgL combinations may signal more efficiently because of their antigen-specificity. 
According to the notion that autoreactive receptors lead to greater signals which result in 
apoptosis, we suggest that through moderate anti-self specificity, some IgH/IgL combinations 
might be able to signal positive selection in the absence of E , when tonic signals are otherwise 
below the necessary threshold. 
To test these hypotheses, we could ask what is the difference between light chains that can and 
cannot support the pre-B to immature B cell transition? The BCR repertoire would be more self-
reactive in VH
a
JH mice than in VHE
a
/ JH mice, or VLs with better signaling properties are 
used more frequently in VH
a
JH mice than in VHE
a
/ JH mice. Immature and splenic B cells 
from mice of both genotypes could be isolated, and the light chain gene sequences cloned by 
PCR, sequenced and compared. Self-reactivity and signaling capacities of these light chains 
could then be tested in cell lines and in an animal model. The prediction is that the light chain 
repertoire in VHE
a
/ JH mice is broader than in VH
a
JH mice, and the limited BCR repertoire 
of VH
a
JH mice might display more self-reactivity or stronger signaling properties. The 
emerging immature B cells are of particular interest. The mature B cells in the spleen are subject 
to additional selection processes, but could also be looked at to see whether there is any 
unexpected consequence with a restricted immature B cell repertoire from which they arise.  
5.4. To what extent does E  contribute to autoreactivity? 
While the VH
a
/WT
b
 model is a very useful system to study E ’s functions in regulating B cell 
differentiation, it also allows for the study of naturally-occurring double-producers with regard to 
their autoimmune risk.
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To gain an appreciation of what proportion of allelically-included B cells carry autoreactive 
receptors in this model, we could work with Dr. Betty Diamond’s lab (The Feinstein Institute for 
Medical Research, North Shore-Long Island Jewish Health Care System, Manhasset, NY), to 
mark cells expressing anti-DNA BCRs and thereby directly enumerate B cells with BCRs 
specific for DNA. The Diamond lab has identified a peptide that serves as a surrogate for DNA 
and that is biotin-labeled (293). When this peptide binds to cells with anti-DNA specificity, the 
cells can be detected by fluorescently-labeled avidin through flow cytometry. By comparing 
single-producers and double-producers from immature and splenic VH
a
/WT
b 
mice, with 
VHE
a
/WT
b
 mice as controls, we expect to see a higher number of DNA-reactive cells among 
VH
a
/WT
b
-double-producers than among VH
a
-single-producers, and we should be able to 
assess the overall frequency of anti-DNA cells among these double-producers. 
In addition, more anti-self specificities could be tested in sera and cells from the VH
a
/WT
b
 mice, 
besides anti-dsDNA specificity. Of particular interest would be anti-self specificities not found in 
WT
b
/WT
b
 mice (i.e. WT
b
-IgH plus IgL with this specificity is completely negatively selected, 
and only the VH
a
-IgH plus IgL with such specificity has a chance to pass negative selection). 
Then we could more precisely test the model for the emergence of autoreactive receptors in 
VH
a
/WT
b
-double-producers.  
Moreover, if we put the VH
a
 allele within an autoimmune mouse background, such as MRL/lpr, 
NZB/NZW or NOD, these autoimmune disease prone models will be more informative if we 
study and characterize their pathology. We predict that these models, incombination with the E -
deficient VH knock-in, will develop more severe symptoms that resemble human SLE or type 1 
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diabetes, including organ malfunction (glomerulitis: proteinuria, elevated BUN, kidney 
histopathology; insulitis: pancreas-specific auto-antibodies, etc) and mortality. 
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